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ABSTRACT 
 
Requirements for Immunity to Virulent Secondary Infection with the Parasite 
Toxoplasma gondii 
 
By 
 
Samantha D. Splitt 
 
Master of Science in Quantitative and Systems Biology 
 
University of California, Merced 2017 
 
Professor Patricia LiWang, Chair 
 
Parasitic infections are a global health burden. The prevention of  parasitic disease  has 
relied heavily on mass drug administration campaigns, vector control, and sanitation rather 
than prevention through vaccination (Mutapi et al. 2013). Among parasites that evade 
effective vaccine induced immunity is Toxoplasma gondii, a ubiquitous intracellular 
protozoan that infects approximately one third of the human population and nearly all 
warm-blooded vertebrates. The adaptive immune response is fundamental to the clearance 
of T. gondii. Previous work by our lab and others’ with commonly studied T. gondii strains 
strongly implicates CD8 T cell functions as the primary immune clearance mechanism 
(Suzuki and Remington, 1988); however, our data also suggests important roles for CD4 T 
cells and B cells. Using a larger array of T. gondii strains sampled from around the world, 
we studied the immunological memory response generated in resistant and susceptible 
mouse genetic backgrounds to secondary infection. We found 1) three host genetic loci 
determine protective immunological memory responses to T. gondii, 2) dysfunctional 
marker profiles are highly expressed on both CD8 and CD4 T cells from the susceptible 
mouse strain, and 3) accumulation of B-1b cells in the resistant mouse strain. We present 
evidence that two of the genetic loci may determine the observed immune cell phenotypes. 
Importantly, as antibody producing cells, B cells may present an advantage in the 
development of effective parasite vaccines as current vaccines are conventionally used to 
induce antibody responses. Understanding the comprehensive immune response to T. 
gondii will provide us with both humoral and cell-mediated immune targets to prevent and 
treat parasitic disease. 
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CHAPTER 1 
 
1. Introduction 
 
1.1 Toxoplasmosis 
 
Toxoplasma gondii is a ubiquitous intracellular protozoan parasite that infects nearly one 
third of the human population and is estimated to infect up to 30 million people in the 
United States (CDC, 2017). T. gondii infects nearly all warm-blooded vertebrates, with 
felines being the definitive hosts, and exhibits a great deal of genetic diversity, especially 
amongst South American strains (Grigg et al., 2001). T. gondii strains are organized 
according to their virulence, with type I and atypical strains being virulent, followed by 
type II and type III strains being relatively avirulent (Howe and Sibley, 1995; Sibley and 
Boothroyd, 1992; Su et al., 2003; Fux et al., 2007). It is one of five neglected parasitic 
infections targeted by the CDC as a priority for public health action (2017). Toxoplasmosis 
is most commonly transmitted through consumption of contaminated food and water. It 
can afflict both healthy and immunocompromised individuals and poses a notable risk to 
mothers who can pass the infection to their unborn babies, resulting in congenital 
toxoplasmosis. Although the host’s immune system typically controls the parasite, 
rendering most infections asymptomatic, severe infection can result when the parasite 
evades the immune response and this can lead to miscarriage, lifelong disabilities, or death. 
T. gondii belongs to the apicomplexan phylum, including Plasmodium spp., the causative 
agent of malaria.  The immune evasion mechanisms used by human parasitic pathogens 
are abundant and have made these parasite infections difficult to prevent. Today we only 
have one parasite vaccine for malaria and its efficacy is very low (25% efficacy; RTS, 
2015). Most, if not all, of our vaccines fail to elicit long-lasting effector T cell responses 
(Siegrist et al. 2008) which are required to kill many parasitic pathogens (Sacks, 2014; 
Coffman and Sher, 1992). To create better therapeutics and immunological preventions 
against parasitic infection we must understand both the humoral-mediated and cell-
mediated immune responses elicited by these pathogens. 
 
1.2 The importance of CD8 T cells for immunity to protozoan 
infections  
 
CD8 T cells are central to protection against many protozoan pathogens of medical 
importance for which we have no protective vaccines. Well-known examples include 
protection against liver stage malaria infection (400 million infections and 500,000 deaths 
per year), and chronic infection with Trypanosoma cruzi, a kinetoplastid parasite of the 
heart and bowels, and the causative agent of Chagas disease (5.7 million infections and 
10,000 deaths per year) (WHO, 2015). Understanding requirements for CD8 T cell-
mediated immunity could have major beneficial impacts on the outcome of parasitic 
diseases. 
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Toxoplasma immunologists have long pointed to the important role of CD8 T cells during 
primary and secondary infection. During secondary infection, CD8 T cells confer immunity 
when challenged with the virulent type I RH strain (lethal dose in naïve laboratory mice = 
1 tachyzoite) (Gazzinelli et al., 1991). CD8 T cells from vaccinated or immune mice can 
be adoptively transferred to naïve recipients and these mice are protected from challenge 
with RH (Gigley et al., 2009a; Suzuki and Remington, 1988). Although a variety of 
immune cells play a role in combating infection, the ability to clear T. gondii infection and 
to confer immunity during secondary infection is unique to CD8 T cells (Bhadra et al., 
2011a). Mice vaccinated with the replication deficient CPS 1-1 strain that are depleted of 
CD4 T cells, but not CD8 T cells, survive challenge with the type I RH strain (Gigley et 
al., 2009a; Jordan et al., 2009). Even during primary infection with less virulent strains, 
CD8 T cells are absolutely required for host survival (Shirahata et al., 1994). CD8 T cells 
from primed mice adoptively transferred to naïve recipients are also protected from ileitis 
after oral infection (Buzoni-Gatel et al., 1997). All of these data indicate CD8 T cells are 
central to protection against T. gondii infection. 
 
Interferon gamma (IFNγ) is a requisite for CD8 T cell defense against T. gondii primary 
infection and immunity to secondary infection (Gigley et al., 2009a). Most strain isolates 
of T. gondii can kill naïve laboratory mice because of IFNγ-resistant virulence factors 
(Melo et al., 2011). However, when mice are vaccinated they are protected against 
challenge with the virulent strain RH, suggesting that immune mice are able to overcome 
the IFNγ-mediated immune evasion strategies employed by T. gondii. While the CD8 T 
cell IFNγ response is necessary to clear T. gondii infection (Suzuki et al., 1988; Gigley et 
al., 2009a), it is not sufficient for all parasite strains (Jensen et al., 2015) and it is not clear 
how this alternative mechanism controls parasite strains that are resistant to IFNγ-mediated 
killing mechanisms. There are several lines of evidence that indicate an unknown 
alternative parasite killing mechanism other than that elicited by IFNγ, 1) T. gondii has 
many virulence factors that resist IFNγ-elicited killing mechanisms that cause lethality in 
naïve mice but are controlled in vaccinated mice, and 2) memory CD4 T cells make copious 
amounts of IFNγ during secondary infection but this cell type  does not alter protection 
when depleted nor confer protection when transferred into a naïve recipient challenged 
with a virulent strain (Gigley et al., 2009a; Jordan et al., 2009; and Suzuki et al., 1989). 
Previous investigation of alternative pathways in the cell-mediated response excluded 
perforin- and FAS-FASL-mediated mechanisms as requirements for protection (Jordan et 
al., 2009), suggesting CD8-T-cell-triggered cytotoxicity and apoptosis of the target cell, 
respectively, are not required for immunity to T. gondii.  
 
1.3 Other requirements for immunity to Toxoplasma gondii 
 
While memory CD8 T cells are vital for secondary infection with the commonly used 
virulent type I RH strain, our data suggests a more expansive role for the immune response 
during secondary infection with diverse strain isolates. For primary infection, innate 
immune cells are the first line of defense against T. gondii infection, especially 
macrophages, dendritic cells, and neutrophils through toll-like receptor signaling (Plattner 
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et al., 2008). Upon TLR 11 signaling, dendritic cells, neutrophils, and macrophages 
produce the cytokine IL-12, which induces Th1 CD4 T cell IFNγ responses (Plattner et al., 
2008). T. gondii PAMPs also trigger TLRs 2 and 4, which induce MyD88 signaling that 
leads to NF-κB activation and the eventual transcription of proinflammatory cytokines 
(Debierre-Grockiego et al., 2007). T cells are not the only IFNγ producers important for 
control of T. gondii infection—neutrophils and natural killer (NK) cells also lead to IFNγ-
mediated clearing of T. gondii (Sturge et al., 2013). Macrophages receive cytokine signals 
and engage in either anti-inflammatory alternative M2 activation (which can be initiated 
by type I and type III strain macrophage infections in vitro) or pro-inflammatory M1 
activation (initiated by type II strains) (Jensen et al., 2011). IFNγ is crucial for M1 
activation and induces several toxoplasmicidal functions in macrophages including nitric 
oxide (NO)-mediated killing, inhibition of growth, and destruction of the parasitophorous 
vacuole through immunity-related GTPases (Yarovinsky, 2014). Like CD8 T cells, CD4 T 
cells are important for producing IFNγ, but they are also necessary in the promotion of B 
cell responses elicited by IgM, IgA, IgE, and IgG antibodies that are capable of controlling 
and killing T. gondii parasites (Kang et al., 2000; Couper et al., 2005; Dupont et al., 2012).  
 
Several studies indicate the important role of the humoral response in immunity against T. 
gondii. In addition to increased CD8 and CD4 T cell responses following T. gondii 
infection, B cell antibody responses are routinely observed. In mice, oral infection elicits 
elevated levels of T. gondii-antigen-specific IgA, IgG, and IgM antibodies and even higher 
levels of antigen-specific IgG and IgM antibodies following i.p. infection (Zorgi et al., 
2016). While vaccination with the type I uracil auxotroph RH strain (RH ∆ompdc) prolongs 
protection against RH challenge in B-cell-deficient Ig-μ KO mice, all mice die by day 27 
following challenge (Gigley et al., 2009a). Additionally, transfer of T. gondii-immune 
serum, but not non-immune serum, into vaccinated B-cell-deficient mice significantly 
prolongs survival after virulent infection with T. gondii  (Sayles et al., 2000). Furthermore, 
Sayles et al. show that vaccinated mice lacking Fc receptors or the fifth component of 
complement (C5) resist virulent infection, suggesting Fc-receptor-dependent phagocytosis, 
antibody-dependent cellular cytotoxicity (ADCC), and antibody- and complement-
dependent lysis of tachyzoites are not important for resistance to virulent challenge (2000). 
Instead, Sayles et al. suggest that B cells function protectively by producing antibodies that 
block infection of host cells by tachyzoites (2000). Work by the same group also showed 
that parasite-specific IgM, but not natural IgM, limited dissemination of tachyzoites during 
early acute infection by blocking host cell invasion (Couper et al., 2005). While B-1 cells 
are conventionally thought of as producers of natural antibody, recent evidence suggests 
they form plasmablasts in response to specific antigens (Covens et al., 2013). While B-
cell-deficient mice do not survive virulent challenge with T. gondii, Chen et al. showed 
that B-1 cells from immunized mice rescue B-cell-deficient mice during virulent T. gondii 
infection (2003). Together, these findings suggest an important role for B cells in immunity 
against T. gondii infection. 
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1.4 Defining new requirements for immunity to Toxoplasma 
gondii 
 
While there is considerable evidence that specific immune cells play an important role in 
combating certain strains of T. gondii, a complete picture of the immune requirements are 
not known for other more virulent strains of this parasite.  By exploring the genetic 
diversity of both parasite strains and mice, we are situated to paint a robust picture of the 
requirements for immunological memory responses to this pathogen. In chapter 3, I analyze 
CD8 and CD4 T cell response during challenge with representative South American strains 
that cause lethal secondary infection.  I attempt to cure disease by modulating key T cell 
inhibitory pathways that we found were highly expressed on these cells during virulent 
infection. These observations will expound upon the extent to which T cell exhaustion 
modulates disease outcome during a virulent T. gondii challenge. In particular, I present 
evidence that modulating these inhibitory pathways may have a limited therapeutic 
potential during secondary infection, and may point to other mechanisms required for 
clearing virulent T. gondii strains.  In chapter 4, I explore host genetics that determine 
disease outcome of secondary infection with T. gondii. I perform a forward genetic screen 
using MHC congenic and recombinant inbred mouse strains. I find that MHC allele type 
matters for host survival to some T. gondii strains but not others, and that there are two 
genetic loci on mouse chromosomes 7 and 10 that control resistance to secondary infection. 
I show evidence that potentially class-switched B-1b cells are protective in resistant mice. 
At the end of chapter 4, I present a new model for how immunological memory might work 
for T. gondii. And finally, in chapter 5, I discuss the development, use, and limitations of 
a transgenic IFNγ:YFP reporter mouse that was generated to track CD8 T cell responses 
during T. gondii infection. 
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CHAPTER 2 
 
2. Materials and Methods 
 
2.1 Cells and Medium 
 
Human foreskin fibroblasts (HFFs) monolayers were grown at 37°C, 5% CO2 in T-25 
flasks for parasite passaging in ‘HFF medium’ (Dulbecco’s modified Eagle’s medium 
[DMEM; Life Technologies] supplemented with 2 mM L-glutamine, 10% fetal bovine 
serum [FBS; Omega Scientific], 1% penicillin-streptomycin [Life Technologies], and 0.2% 
gentamycin [Life Technologies]. T-25 flasks were made by splitting T-175 flasks 1:50. T-
175 flasks were washed with 20 mL sterile PBS and 3 mL trypsin was added. Flasks were 
incubated for 10 min at 37°C, 5% CO2. Monolayers were agitated by tapping the flask and 
200 mL HFF medium was added; 4 mL of cell suspension was placed in each T-25 flask. 
T-25 flasks were ready for passaging after 1-2 weeks.  
 
Bone marrow-derived macrophages (BMDMs) were generated by dissecting the femurs, 
tibias, and fibulas from C57BL/6 or 45.1 C57BL/6 mice. The bones were placed in 10 mL 
of BMM (bone marrow macrophage) medium (10% FBS, 1% MEM NEAA [minimal 
essential medium non-essential amino acids; Life Technologies], 1% sodium pyruvate 
[Life Technologies], and 1% penicillin-streptomycin). Bones were crushed with mortar and 
pestle, rinsed with 10 mL BMM medium, crushed again, and filtered through a 70µm nylon 
filter.  Bones were ground, rinsed, and filtered a second time. The suspension was then 
spun at 1500 rpm for 5 min and resuspended in 4 mL ACK red blood cell (RBC) lysis 
buffer (NH4Cl at 0.15 M, KHCO3 at 10 mM, EDTA at 0.1 mM) for 5 min at room 
temperature, quenched with 16 mL BMM medium, washed in 10 mL BMM medium and 
filtered through at 70µm filter. Cells were then pelleted, and resuspended BMM medium 
supplemented with 20% L929, plated in 8 non-tissue culture treated petri dishes (10 mL 
per plate), and grown to 90-100% confluency at 37°C, 5% CO2 for 7 days. To harvest, cells 
were washed with sterile PBS, scraped, collected in a 50mL conical tube, and spun at 1500 
rpm for 5 min. BMDMs were stored (1 x 107 cells per vial) in 10% DMSO in BMM 
medium at -160°C. For in vitro T-GREAT T cell assays and parasite assays, BMDMs were 
plated in 96-well plates at 1 x 105 – 2 x 105 per well in BMM medium. All counting of live 
cells was performed by trypan blue dye exclusion.  
 
2.2 Parasite strains 
 
Toxoplasma gondii strains were passaged in human foreskin fibroblasts (HFFs) in ‘Toxo 
medium’ (4.5 g/L D-glucose, L-glutamine in DMEM supplemented with 1% FBS and 1% 
penicillin-streptomycin). The following clonal strains were used (clonal types are indicated 
in parentheses): RH Δku80 (type I), RH1-1 (type I), GT1 (type I), Pru A7 fLUC 
Δhxgprt::HXGPRT (5-8 B+) (type II), Pru Δhxgprt Δku80 (type II), and CEP hxgprt-  (type 
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III). The replication-deficient uracil auxotroph vaccine strain RH Δku80 Δompdc 
Δup::HXGPRT was grown in Toxo medium supplemented with 10 mM uracil. The 
following atypical strains were used: MAS (haplogroup HG4), GUY-MAT (HG5), FOU 
(HG6), GPHT (HG6), TgCATBr5 (HG7), GUY-DOS (HG10), and VAND (HG10). 
 
2.3 Generation of GFP-expressing and tomato-expression GT1 
strains 
 
GT1 parasites were transfected with linearized plasmids for parasite expression of Td-
Tomato [gifted by M. Melo, MIT] and GFP cLuciferase (Saeij et al., 2005) parasites were 
grown on HFF monolayers in T-25 flasks in Toxo medium for 2 weeks. Parasites were 
removed from the flasks by scraping; the parasites were pelleted and washed with PBS and 
resuspended in sterile FACS buffer (2% FBS in PBS). Fluorescent parasites where then 
sorted via fluorescence-activated cell sorting (FACS) into a 96-well plate. To ensure single 
plaque formation in at least one of the wells, the sort was titrated using the following 
parasite numbers: 100, 50, 25, 12, 6, 3, 2, and 1 for each well per row of 8.  
 
2.4 Mice 
 
Female C57BL/6J (H-2b), A/J (H-2a), C57BL/10SnJ (H-2b), B10.A-H2a H2-T18a/SgSnJ 
(H-2a), B6AF1/J F1 A/J x C57BL/6J progeny, B6.129S2-Cd8atm1Mak/J (CD8 knockout), 
and A/J x C57BL/6 recombinant inbred mice were purchased from Jackson Laboratories 
and maintained under specific pathogen free conditions. B6.SJL-Ptprca Pepcb/BoyJ 
(CD45.1+) mice were acquired from the Manilay laboratory (UC Merced) and were bred 
in-house. T-GREAT mice were obtained by crossing T57 mice (Ploegh laboratory, MIT) 
with GREAT mice (Reinhardt et al., 2009) [Jackson Laboratories]. T57 transnuclear mice 
were generated by somatic cell nuclear transfer of Kb TDG05796–103 tetramer-positive CD8 
T cells (C57BL/6 background), and thus 90% of peripheral CD3+ T cells are CD8+ and 80 
to 90% of these have endogenously rearranged TCRα (Vα6-4) and β (Vβ13-1) loci with 
encoded CDR3 regions bearing specificity for Kb-TGD05796–103 (Kirak et al., 2010). 
GREAT (interferon-gamma reporter with endogenous polyA transcript) mice have an 
IRES-eYFP reporter cassette inserted between the translational stop codon and 3’ 
UTR/polyA tail of the interferon gamma gene.  
 
2.5 Ethics Statement 
 
Every effort was made to ensure unnecessary stress on the animals was avoided. Mouse 
work was performed in accordance with the National Institutes of Health Guide to the Care 
and Use of Laboratory Animals. All protocols have been reviewed and approved by UC 
Merced’s Committee on Institutional Animal Care and Use Committee. UC Merced has an 
Animal Welfare Assurance filed with OLAW (#A4561-01), is registered with USDA (93-
R-0518), and the UC Merced Animal Care Program is AAALAC accredited (001318). 
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2.6 Primary infection and serotyping 
Parasite injections were prepared by scraping T-25 flasks containing vacuolated HFFs and 
sequential syringe lysis first through a 25G needed followed by a 27G needle. The parasites 
were spun at 400 rpm for 5 min and the supernatant was transferred, followed by a spin at 
1700 rpm for 7 min. The parasites were washed with 10 mL phosphate-buffered saline 
(PBS), spun at 1700 rpm for 7 min, and resuspended in PBS. For chronic infections or 
adoptive transfer experiments, mice were infected intraperitoneally (i.p.) with 104 
tachyzoites in 200 µL PBS with CEP hxgprt-; for direct infection of T-GREATs or for 
adoptive transfer experiments, Pru Δhxgprt Δku80 or RH Δku80 Δompdc were used at the 
same dose. Parasite viability of the inoculum was determined by plaque assay following 
i.p. infections. 100 or 300 tachyzoites were plated in HFF monolayers grown in a 24-well 
plate and 4-6 days later were counted by microscopy (4x objective). 
Between 30-35 days following chronic infection, 50 uL of blood was harvested from mice 
from the tail vein, collected in tubes containing 5 uL 0.5M EDTA, and placed on ice. The 
blood was pelleted at 10,000 rpm for 5 min; blood plasma was collected from the 
supernatant and stored at -80°C. To evaluate seropositivity of the mice, HFFs were grown 
on coverslips and infected with GFP-expressing Pru A7 fLUC Δhxgprt::HXGPRT (5-8 B+) 
or RH1-1 overnight, fixed 18 hours later with 3% formaldehyde in PBS, permeabilized 
with 3% bovine serum albumin, 0.2M Triton X-100-0.01% sodium azide, incubated with 
a 1:100 dilution of collected blood plasma for 2 hours at room temperature, washed with 
PBS, and detected with Alexa Fluor 594-labeled secondary antibodies specific for mouse 
IgG [Life Technologies]. Seropositive parasites were observed by immunofluorescence 
microscopy.  
2.7 Secondary infections and assessment of parasite viability 
 
Seropositive mice were challenged with 5 x 104 syringe-lysed parasites and weighed every 
3-4 days for survival experiments or euthanized on D5 for FACS experiments. Parasite 
viability for each strain was determined by plaque assay following completion of 
injections.  
 
2.8 Genetic linkage analysis 
 
Quantitative trait loci (QTL) analysis was performed with the program R/QTL [Bowman]. 
LOD scores for each marker were calculated. For all LOD scores >2, 1,000 permutations 
were performed to obtain the LOD threshold at a P value of ≤0.05, which was considered 
statistically significant.  
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2.9 Brain superinfection assays 
 
Brains from chronically infected mice (CEP hxgprt-) that survived secondary challenge 
were dissected, rinsed in PBS, placed in 5 mL PBS in a 10mL syringe, and passed through 
a 21G needle several times. The suspension was spun at 1700 rpm for 7 min and 
resuspended in 1 mL of PBS. For rederivation, 200 uL of the brain homogenate was used 
to inoculate T-25 flasks containing HFF monolayers in Toxo medium. Two weeks later, 
infected HFFs were syringe-lysed and plated on new HFF monolayers to encourage 
parasite growth. Once HFFs were fully vacuolated, parasites were passaged onto new HFF 
monolayers in mycophenolic acid – xanthine (MPA xanthine) medium which selects for 
parasites encoding a functional HXGPRT (i.e. the challenging strains).  
 
2.10 Cell isolation, in vitro recall infections, and FACS analysis 
 
To isolate peritoneal exudate cells (PECs) by peritoneal lavage, 4mL of PBS and 3mL of 
air were injected into the peritoneal cavity with a 27G needle. After shaking, the puncture 
was expanded with scissors and the PEC wash was poured into a conical tube. PEC washes 
were filtered through a 70µm cell strainer, pelleted, and washed with FACS buffer (PBS 
with 1% FBS) before staining. Peripheral lymph nodes (PLNs; axillary, brachial, and 
inguinal) were dissected and crushed through 70µm cell strainers, pelleted, and washed in 
FACS buffer. Spleens and mesenteric lymph nodes (MLNs) were dissected and crushed 
through 70µm cell strainers, pelleted, resuspended in ACK RBC lysis buffer, quenched 
with ‘T cell medium’ (10% FBS in RPMI 1640 with GlutaMAX, antibiotics, 10 mM 
HEPES, 1 mM sodium pyruvate [Life Technologies], and 1.75 µl β-mercaptoethanol per 
500 ml [MP Biomedicals]). 
 
For FACS analysis, all preparations were done on ice, and cells were blocked in FACS 
buffer containing Fc Block anti-CD16/32 [2.4G2; BD Biosciences], 5% normal hamster 
serum, and 5% normal rat serum [Jackson ImmunoResearch] prior to staining with 
fluorophore-conjugated monoclonal antibodies (mAbs). The following mAbs (1:100 
staining dilutions) were purchased from eBioscience: anti-CD11c-eFlour 450 (N418), anti-
CD45.2-eFlour 450 (104), anti-CD4-eFlour 450 (GK1.5), anti-CD62L-eFlour 450 (MEL-
14), anti-CD11b-FITC (M1/70), anti-KLRG1-FITC (2F1), anti-CD8α-FITC (53-6.7), anti-
PD-1-PE (J43), anti-IFNγ-PE (XMG1.2), anti-TIM-3-PE (RMT3-23), anti-CD8α-PE (53-
6.7), anti-CD137/41bb-PE (17B5), anti-PD-1-APC (J43), anti-Ly6G-APC (1A8-Ly6g), 
anti-CD8α-APC (53-6.7), anti-CD19-PerCP/Cy5.5 (ebio1D3), anti-CD3-eFlour 710 
(17A2), anti-CD3-eFlour 780 (17A2), anti-CD4-PECy7 (GK1.5), and anti-Ly6C-PECy7 
(HK1.4). The following mAbs were purchased from BioLegend: anti-CD8α-BV510 (53-
6.7), anti-41bbL-PE (TKS-1), anti-CD45.1-PECy7 (A20), anti-CD23-Pacific Blue (B3B4), 
anti-CD21/CD35-FITC (7E9), anti-CD19-PE (6D5), anti-CD5-APC (53-7.3), anti-
CD45R/B220-APC/Cy7 (RA3-6B2), and anti-IgM-PECy7 (RMM-1). The following 
antibodies were purchased from BD Biosciences: anti-CD152/CTLA-4-PE (UC10-4F10-
11), and anti-CD11b-BUV395 (M1/70). Other FACS reagents included the viability dyes 
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propidium iodide [Sigma] at a final concentration of 1 ug/mL and fixability dye 506 
[eBioscience] at 1:100, the stimulatory antibodies anti-CD28 [37.51; BD Biosciences] and 
anti-CD3ε in NA/LE buffer (no azide, low endotoxin buffer) [145-2C11, BD Biosciences], 
and CalbriteTM APC beads [BD Biosciences].  
 
For in vitro recall, peritoneal lavage was performed on chronic and challenged (day 5 
following secondary infection) A/J and C57BL/6 mice. PECs were filtered through a 70µm 
cell strainer, washed in FACS buffer, and 6 x 105 PECs or splenocytes per well (96-well 
plate) were plated in T cell medium. Cells were infected with the type I RH strain at an 
MOI (multiplicity of infection) of 0.2 for 18 hr; 3µg/mL brefeldin A, 1x [eBioscience] was 
added for the last 5 hr of infection. 96-well plates were placed on ice, cells were harvested 
by pipetting and washed with FACS buffer, blocked, and stained for surface markers 
(described above). Next, cells were fixed with BD Cytofix/Cytoperm and permeabilized 
with BD Perm/Wash solution [BD Pharmingen]. Cells were then stained with anti-IFNγ-
PE (XMG1.2) on ice for 1 hr. Cells were then washed once with BD Perm/Wash solution, 
once in FACS buffer, and analyzed by FACS.  
 
For in vitro stimulation of T-GREAT T cells, 2 x 105 BM macrophages were plated in a 
96-well plate and 1ug/mL soluble anti-CD3ε antibodies were added for 1 hr prior to adding 
5 x 105 purified T-GREAT splenic- and PLN-derived T cells to the culture. Cells were 
harvested 24 hr later and analyzed by FACS.  
 
2.11 Adoptive transfers 
 
CD8 T-GREAT cells were isolated by negative selection using an EasySep™ Mouse CD8+ 
T Cell Isolation Kit, according to the manufacturer’s protocol. Cells were then washed with 
PBS, resupended in PBS, and kept on ice for injection. Adoptive transfer was performed 
by injecting 1 x 106 – 5 x 106 45.2+ T-GREAT CD8 T cells intravenously through the tail 
vein (200 uL) or intraorbitally (100 uL) into 45.1+/45.2+, 45.1+, or CD8 knockout mice. For 
intraorbital injections, mice were placed under anesthesia using isofluorane. Recipient 
mice were then injected 2-12 hours later with 1 x 104 CEP hxgprt-  type III or ME49 type 
II parasites. On days 8, 9, or 35 PECs and spleens from recipient mice were evaluated via 
FACS analysis for CD8 T-GREAT expansion.  
2.12 Neutralization 
 
C57BL/6 mice were chronically infected with 104 CEP hxgprt-  type III parasites followed 
by challenge 35 days later with 5 x 104 virulent GT1 type I parasites. Mice were injected 
with 200µg of blocking antibodies [anti-TIM-3 (RMT3-23), anti-PDL-1 (B7-H1), and rat 
IgG2b isotype control, all purchased from BioXCell] at days 1, 3, 5, 7, 10, and 13 post 
challenge. Antibody injections were prepared in 200µL of sterile PBS. Mouse survival and 
weight was monitored for 27 days.  
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CHAPTER 3 
 
3.1 Introduction 
 
3.1.1 CD4 and CD8 T cell exhaustion  
 
T cell exhaustion is a state of T cell dysfunction characterized by hyporesponsiveness, 
wherein T cells produce fewer cytokines and cytotoxic molecules, lower expression of 
activating receptors, and increase expression of inhibitory receptors (Wherry, 2011). T cell 
exhaustion was first characterized in chronic viral infection models (Zajac et al., 1998), but 
is now widely studied in cancer, bacterial infection, and parasitic infection models (Bhadra 
et al., 2011a; Stager, et al., 2009; Butler et al., 2012; Virgin et al., 2009). The molecular 
signature of CD4 and CD8 exhaustion has been thoroughly defined in recent years and 
several markers have been identified to distinguish these dysfunctional T cell states 
(Wherry et al., 2007; Crawford et al., 2014). Several key markers have been identified that 
label CD8 or CD4 T cells as exhausted: 1) high expression of the inhibitory receptors PD-
1, LAG-3, BTLA, 2B4, CTLA-4, TIM-3, and others, 2) lowered expression of the 
costimulatory receptors 4-1bb, ICOS, and OX40, and 3) differential expression of the 
transcription factors Tbet, Eomes, BLIMP-1, and others (Wherry and Kurachi, 2015; 
Wherry et al., 2007; Crawford et al., 2014; Sakuishi et al., 2010). Exhausted T cells may 
carry most, or a portion of, these markers; marker expression varies with disease model, 
progression of disease state, and cell type.  
 
3.1.2 T cell exhaustion during Toxoplasma gondii infection 
 
CD4 and CD8 T cells both play important roles in protection during T. gondii infection; 
however, the requirement for CD8 T cells and their IFNγ response, above all other cell 
types, has been shown to be necessary through depletion and adoptive transfer studies in 
C57BL/6 mice using the highly passaged type I lab strain RH (Gigley et al., 2009a; Suzuki 
et al., 1988). CD8 T cell exhaustion during chronic T. gondii infection is defined by loss 
of polyfunctionality: loss of cytotoxicity (measured by granzyme B production, GzmB) 
and loss of production of the pro-inflammatory cytokines IFNγ and TNFα; exhausted CD8 
T cells exist on a spectrum in which they are able to produce two, one, or none of these 
functional indicators (Bhadra et al., 2011a; Długołńska and Grzybowski, 2013; Hwang, S. 
et al., 2016). CD8 T cell exhaustion during T. gondii infection has been predominantly 
defined by elevated expression of the inhibitory receptor PD-1 along with decreased 
effector functions like IFNγ, TNFα, and GzmB production (Bhadra et al., 2011a; 
Długołńska and Grzybowski, 2013). Bhadra et al. were able to rescue exhausted CD8 T 
cells and parasite recrudescence following blockade of the PD-1 ligand (2011a).  Later 
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work by the same group showed CD4 T cell exhaustion is more pronounced—greater 
expression of inhibitory receptors, and decreased expression of costimulatory receptors and 
the cytokines IFNγ and TNFα—than CD8 T cell exhaustion during chronic T. gondii 
infection, and that this is mediated by the transcription factor BLIMP-1 (Hwang et al., 
2016). Hwang et al. showed that deletion of BLIMP-1 from CD4 T cells not only restores 
CD4 T cell function, but also CD8 T cell function (2016).  
 
While primary infection with avirulent T. gondii strains can induce protective memory 
responses to virulent strains upon secondary infection, this is not true for all strains—
namely, the atypical strains (Jensen et al., 2015). We hypothesized that susceptibility to 
secondary infection may be due to dysfunctional T cell responses caused by more virulent 
atypical T. gondii strains. Moreover, we also predicted that by correcting the T cell 
dysfunction, mouse survival to lethal secondary infection may be enhanced. We tested 
these hypotheses with the following experiments.  
 
 
 
 
 
 
Table 1. Description of common markers associated with T cell exhaustion and some of their 
functions.  
Exhaustion Marker Immunological Function
2B4 (CD244)
Inhibitory/Stimulatory. Mostly found on memory CD8 T cells and NK cells and its ligand, CD48, is 
expressed on hematopoietic cells. Decreases survival of memory T cells during secondary LCMV 
infection (West et al., 2011). Activates and represses lymphocytes depending domain binding 
(McNerney et al., 2004).
41bb (CD137)
Stimulatory. Mostly expressed on activated T cells, moreso on CD8 T cells than CD4 T cells. Enhances 
T cell proliferation and survival, cytolytic activity, and IL-2 secretion (Wang et al., 2009; Long et al., 
2015).
Inhibitory (Ishida, Y. et al., 1992; Freeman, G.J. et al., 2000). Promotes apoptosis of antigen-specific T 
cells and reduces apoptosis of Tregs. Downregulates inflammatory cytokine production and induces 
suppressive cytokines (i.e. IL-10). 
Inhibitory (Monney et al., 2002; Zhu et al., 2005). Found on IFNγ-producing CD8 CTLs and CD4 Th1 
cells. Suppresses TCR activation (Tomkowicz et al., 2015). Induces alternative activation (suppressive) 
and represses classical activation (inflammatory) of macrophages (Zhang et al., 2017). Also found on 
Tregs in cancer models, where its presence induces suppression (Anderson, 2014). 
Inhibititory (Brunner et al., 1999). Upregulates on activated T cells and constitutively expressed on 
Tregs. Binds CD80/86 on APCs with greater affinity than its costimulatory counterpart CD28 (Dyck 
and Mills, 2017). 
PD-1 (CD279)                                
Programmed cell death protein 1
TIM-3 (HAVCR2)                                          
T-cell immunoglobulin and mucin-domain 
containing-3
CTLA-4 (CD152)                                 
Cytotoxic T-lymphocyte-associated protein 4
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3.2 Results 
 
3.2.1 During secondary infection, virulent Toxoplasma gondii 
strains elicit an enhanced CD4 and CD8 T cell exhaustion 
marker profile 
 
We first evaluated the exhaustion profiles of CD8 T cells using several conventional 
exhaustion markers (Table 1) following secondary infection with virulent atypical T. gondii 
strains because these cells play a dominant role in controlling T. gondii infection. Our 
model is to first prime C57BL/6 mice intraperitoneally (i.p.) with the type III avirulent T. 
gondii strain CEP hxgprt- and then, 35 days later, mice are reinfected with the atypical 
strains, MAS and GUY-DOS, or the highly passaged type I lab strain RH. In naïve mice, 
it is known that these strains cause a lethal primary i.p. infection (Su et al., 2003; Fux et 
al., 2007; Jensen et al., 2015); however, during secondary infection MAS and GUY-DOS, 
but not RH, produce a lethal outcome in C57BL/6 mice (Jensen et al., 2015).  
 
The T cell populations we analyzed were designated by CD62L (L-selectin) and KLRG1 
(killer cell lectin-like receptor G1). CD62L is a cell adhesion molecule found on 
lymphocytes and is important for homing lymphocytes into the T cell zone of secondary 
lymphoid tissues; CD62L is found on naïve T cells and central memory T cells (TCM) 
(Masopust and Schenkel, 2013). Memory T cells, or antigen-experienced T cells, are 
important for mounting a swift and robust response to secondary encounters with an 
antigen. TCM cells, like naïve T cells, express CCR7, a chemokine receptor that engages 
with the ligands CCL19/21 in the peripheral lymphoid organs, thereby homing these cells 
to these tissues (Ohl et al., 2003). Additionally, TCM cells produce a very minimal repertoire 
of cytokines, namely IL-2, but following differentiation into effector T cells in response to 
TCR triggering by antigen, these cells also produce large amounts of IL-4 and IFNγ 
(Sallusto et al., 2003). Effector memory (TEM) cells are active, cytokine-producing cells 
that, like effector T cells, do not express CD62L or CCR7; instead, they express 
inflammatory chemokine receptors that home these cells to the site of infection. KLRG1 is 
a transmembrane protein found on lymphocytes that marks highly activated, terminally 
differentiated effector T cells and TEM cells (Robbins et al., 2003; Wilson et al., 2010). TEM 
and TCM, designated using CD62L and KLRG1, have been noted to have different 
requirments for IL-12 during differentiation and the ability to make IFNγ during T. gondii 
infection (Wilson et al., 2008; Wilson et al., 2010). It should be noted that these studies 
often use tetramers to define their memory populations, which are then correlated to 
surrogate markers—CD62L and KLRG1 in this case. However, we have not used tetramer 
staining so the population that we loosely define as TCM-like and TEM-like also includes 
other cells, namely naïve T cells in the CD62L+ population and effector T cells in the 
CD62L- population.  Using this staining approach, we noted that the frequencies of CD62L- 
T cells isolated from the peritoneal cavity increase following chronic infection. However, 
on day 5 of secondary infection the relative frequencies of each population remained 
constant (Fig. 1, A and B).   
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We next evaluated the cell surface expression of several inhibitory markers and one 
activation marker associated with T cell exhaustion in the LCMV model (Wherry et al., 
2007; Crawford et al., 2014)—PD-1, TIM-3, CTLA-4, 2B4, and 4-1bb—on T cells isolated 
from the peritoneal cavity (Table 1 and Fig. 1, left), as this site exhibits a robust T cell 
response to i.p. infection with T. gondii (Wilson et al., 2010). PECs (peritoneal exudate 
cells) from mice challenged with atypical strains exhibited increased expression of PD-1, 
TIM-3, and 4-1bb on CD8 T cells—most strikingly in the CD62L-KLRG1+/- (TEM-like) 
populations—compared to chronic and RH-challenged mice (Fig. 1, left).  
Figure 1. Frequencies of effector populations following chronic and secondary infections with 
Toxoplasma gondii. A) Representative FACS plots of PEC CD4 and CD8 T cells and their expression of 
CD62L and KLRG1 from naïve C57BL/6 mice, from mice that were infected with the the type III CEP 
hxgprt- strain and allowed to progress to chronic infection for 35-45 days, or from chronically infected mice 
that were challenged with the indicated T. gondii strains on day 5. B) Quantificiation of the relative 
frequencies of the indicated populations; each dot represents the data from one mouse. P values were 
calculated using ANOVA testing; *P < 0.05 was considered significant. 
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Figure 2. Expression of exhaustion markers on CD4 and CD8 T cells is enhanced following 
challenge with virulent strains of Toxoplasma gondii. PECs were harvested from C57BL/6 mice that 
were chronically infected with T. gondii (type III CEP hxgprt- strain), or on D5 post secondary infection 
(i.p.) with indicated T. gondii strains. The frequency of CD62L+KLRG1- (CD62L+), CD62L-KLRG1-, or 
CD62L-KLRG1+ (KLRG1+) that express the indicated marker among total CD8+CD3+ PECs (left, top) 
or total CD4+CD3+ PECs (right, top) are shown; each dot is representative of an individual mouse. P 
values were obtained by ANOVA testing of the challenged mice; *P values < 0.5 and **P < 0.01 are 
considered significant. Representative histogram plots of CD62L+, CD62L-KLRG1-, or KLRG1+ on 
CD8+CD3+ CD19- PECs (left, bottom) or CD4+CD3+ CD19- PECs (right, bottom) that express the 
indicated exhaustion marker are shown. Chronic/no challenge (red), RH (green), MAS (blue), and GUY-
DOS (orange). Cummulative data from four separate experiments for CD8 T cell data (left, top and 
bottom); cumulative data from two separate experiments for CD4 T cell data, (right, top and bottom).  
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We similarly evaluated the same surface marker profile on CD4 T cells in the PECs (Fig. 
1, right). PEC CD4 T cells showed the same general trend as the CD8 T cells in increasing 
exhaustion marker expression in response to challenge with atypical strains, although there 
were two notable differences. First, CD4 T cell expression differences following secondary 
infection with atypical strains compared to cells from chronic and RH-challenged mice 
were more apparent.  Second, CTLA-4, an inhibitory receptor more highly expressed on 
CD4 T cells during exhaustion in the LCMV model (Crawford et al., 2014) and 
constitutively expressed on regulatory T cells (Egen et al., 2002) was elevated in the CD4 
CD62L- (TEM-like) population in response to atypical strain challenge (Fig. 1, right). We 
did not look at 2B4 expression on CD4 T cells.  
 
Additionally, we evaluated coexpression of exhaustion markers during chronic and 
secondary infection with T. gondii. We observed that PD-1 expression correlated strongly 
with several other exhaustion markers—CTLA-4, TIM-3, and 4-1bb—on both CD4 and 
CD8 T cells (Fig. 3). Again, we found this trend to be more apparent in CD4 T cells than 
in CD8 T cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Co-expression of exhaustion markers on CD4 and CD8 T cells is enhanced following 
challenge with virulent strains of Toxoplasma gondii. PECs were harvested from C57BL/6 mice that 
were chronically infected with T. gondii (type III CEP hxgprt- strain), or on D5 post secondary infection 
(i.p.) with indicated T. gondii strains. The frequency of CD62L+KLRG1- (CD62L+), CD62L-KLRG1-, or 
CD62L-KLRG1+ (KLRG1+) that express the indicated marker among total CD8+CD3+ PECs (left) or 
total CD4+CD3+ PECs (right) are shown; each dot is representative of an individual mouse. P values were 
obtained by ANOVA testing of the challenged mice; *P < 0.5, **P < 0.01, and ***P < 0.001 are 
considered significant.. Cummulative data from four separate experiments for CD8 T cell data (left); 
cumulative data from two separate experiments for CD4 T cell data (right).  
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3.2.2 Despite exhaustion profiles in both CD4 and CD8 T cells, 
only CD8 T cells show impaired IFNγ production 
 
To assess whether CD4 and CD8 T cells made IFNγ, the critical effector cytokine required 
for survival to T. gondii infection (Yarovinsky, 2014), its expression was measured by in 
Figure 4. CD8 T cells are less capable of producing IFNγ following following challenge with virulent 
atypical Toxoplasma gondii strains, while CD4 T cells are not impaired. In vitro recall was performed 
on PECs harvested from C57BL/6 mice challenged with the indicated T. gondii strain and were infected 
(recalled) with one of the following T. gondii strains, type I RH or MAS; 24 hours later, intracellular 
staining for IFNγ and FACS analysis was performed. A) Quantification of IFNγ expression in CD4 (left) 
or CD8 (right) T cells following no challenge, challenge with type I RH, or challenge with the atypical 
strains MAS and GUYDOS. P values were calculated by ANOVA testing; *P < 0.05, **P < 0.01, and 
***P < 0.001 were considered significant. B) Representative FACS plots showing intracellular IFNγ 
expression on CD8 T cells following RH or MAS challenge, during no recall, RH recall, or MAS recall. 
The IFNγ response was independent or strain type used in the in vitro recall assay. Data is representative 
of 2-3 experiments; n = 3-8 mice per experiment. C) CD8 T cell splenocytes were analyzed for IFNγ as 
in panel B. D) Average frequency of the indicated populations among total CD8 T cell splenocytes are 
shown; +/- SEM, results are compiled from 1-2 experiments.  
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vitro recall and intracellular FACS analysis. PECs were harvested from C57BL/6 mice 
following secondary challenge with the atypical strains MAS or GUY-DOS, the highly 
passaged lab strain RH, or no secondary challenge. PECs were then infected with T. gondii 
and evaluated 16 hours later for IFNγ expression. CD8 T cells challenged with virulent 
atypical, but not the RH, strains displayed a diminished capacity to produce IFNγ (Fig. 4A, 
right and Fig. 4B). In contrast, despite CD4 T cells exhibiting an exhausted surface marker 
profile, their IFNγ expression was not impaired, but rather, increased following challenge 
(Fig. 4A, left).  
 
Additionally, we evaluated the spleen following virulent challenge and observed very little 
IFNγ response or exhaustion marker profile differences between RH and MAS secondary 
challenges (Fig. 4, C and D). It should also be noted that low splenic responses as compared 
to the PECs are also observed following vaccination with a replication-deficient type I RH 
strain (Gigley et al., 2009b) and this may represent a general feature of i.p. injections with 
less virulent T. gondii strains (Jensen et al., 2015).   
 
3.2.3 Neutralization of PDL-1 and TIM-3 fails to rescue 
exhausted CD8 T cells following virulent challenge 
 
PD-1—PDL-1 neutralization proved effective in rescuing CD8 T cell function during 
chronic infection with type II ME49 T. gondii in a previous study (Bhadra et al., 2011a), 
Figure 5. Neutralization with αTIM-3 and αPDL-1 blocking antibodies fails to rescue C57BL/6 
mice following virulent secondary challenge. C57BL/6 mice were primed with 1 x 104 type III avirulent 
T. gondii CEP hxgprt-  parasites; then, 35 days later, mice were challenged with 5 x 104 type I virulent 
GT1 T. gondii parasites. A) Representative FACS histograms showing PD-1 expression in TEM-like 
CD3+CD8+ CD19- CD62L-KLRG1+/- populations during chronic infection, RH challenge, and GT1 
challenge. B) Following GT1 challenge, mice were injected (i.p.) with 200 µg of the following 
monoclonal antibodies: rat IgG2b isotype (n = 9), αPDL-1 (n = 10), αTIM-3 (n = 5), or αPDL-1/αTIM-
3 (n = 9) on days 1, 3, 5, 7, 10, and 13 after challenge. Survival was monitored daily. Cummulative data 
from two separate experiments are plotted, with the exception of αTIM-3 which is the result of one 
experiment. For each therapeutic cohort,  P values were calculated by Log-rank (Mantel-Cox) testing 
against the isotype control; no P values were significant. P < 0.05 was considered significant. 
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but has not been tested during secondary challenge with virulent T. gondii strains. To test 
whether we could reverse T cell exhaustion following virulent challenge and promote host 
survival, we administered a neutralizing antibody regimen by blocking the pathways of the 
inhibitory receptors most highly expressed on C57BL/6 mice in our experiments (Fig. 2), 
TIM-3 and PDL-1. Although we did not measure PDL-1 expression, treatment with 
blocking antibodies against the PD-1 ligand is the convention (Keir et al., 2008). In this 
experiment, the GT1 type I strain was used as it induces a lethal secondary infection in 
C57BL/6 mice (Jensen et al., 2015), and induces expression of PD-1 on CD62L- TEM-like 
CD8 T cells following challenge (Fig. 5A). Blocking these pathways failed to rescue mice 
(Fig. 5B). Whether the mice died from parasite burden or cytotoxicity is not known.  
 
3.3 Discussion 
 
3.3.1 CD4 and CD8 T cell function are intertwined during 
secondary infection with virulent Toxoplasma gondii 
 
Our data suggest that both CD4 and CD8 T cells express markers associated with T cell 
exhaustion following challenge with virulent T. gondii strains. However, the individual 
impact of each of these cell types in this context is not yet resolved. CD4 T cell help to 
CD8 T cells conventionally occurs by activation of antigen-presenting cells (APCs) 
through CD40-CD40L interactions. However, it has also been shown that CD40 expression 
on CD8 T cells facilitates direct CD4 T cell help and that this is necessary for CD8 T cell 
memory (Bourgeois et al., 2002). Bhadra et al. suggests the CD40-CD40L pathway plays 
an important role in the rescue of exhausted CD8 T cells during chronic T. gondii infection 
(2011b). Although inducing CD40-CD40L interactions had minimal effects in 
reinvigorating exhausted CD8 T cells during chronic T. gondii infection,  cotreatment of 
both αCD40L and αPDL-1 rescued CD8 T cells more effectively than αPDL-1 treatment 
alone (Bhadra et al., 2011b). Our data might suggest an important role for CD4 T cell help, 
that fails to be propagated while the cells are exhausted. Further studies should be 
conducted to assess the function of the CD40-CD40L pathway during virulent secondary 
challenge with T. gondii.  
 
Although TIM-3 is highly expressed on CD4 and CD8 T cells following virulent challenge, 
previous studies in viral models show that the state of progression of T cell exhaustion 
matters during rescue, and perhaps, T cells, following virulent secondary T. gondii 
infection, are too exhausted to be rescued. Exhausted T cells that are T-bethi and PD-1mid 
are more inclined to be rescued by inhibitory receptor blockade, while exhausted T cells 
that are EOMEShi and PD-1hi are more prone to die following blockade (Wherry and 
Kurachi, 2015). Additional blocking antibodies against other inhibitory receptors—for 
example, CTLA-4, should be tested following virulent secondary challenge with T. gondii. 
Anti-CTLA-4 treatment has proven effective in restoring exhausted CD4 T cell function in 
several cancer studies (Dempke et al., 2017). Costimulatory receptor agonists to enhance 
CD40 and 4-1bb, for example, might also be explored (Long et al., 2015).  
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3.3.2 T cell function may be insufficient for protection against 
secondary infection with virulent Toxoplasma gondii 
 
While CD8 T cells play an absolutely necessary role in survival against challenge with 
some T. gondii strains, like RH, there are likely additional requirements for immunity to 
more virulent T. gondii strains. If restorative treatments for T cell exhaustion fail, then this 
suggests susceptibility to virulent secondary challenge may not be controlled only by 
exhaustion. Although the exhausted T cell phenotype correlates with increasing parasite 
virulence, it may not be the driving factor for host susceptibility. To uncover other potential 
requirements for immunity to virulent secondary challenge, we turned to mouse genetics.  
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CHAPTER 4 
 
4.1 Introduction 
 
4.1.1 Toxoplasma gondii seeks a balanced infection in its many 
hosts 
 
Toxoplasma gondii infects a wide breadth of hosts ranging from humans to birds to sea-
dwelling animals. Because of this host diversity, T. gondii has garnered a highly adaptable 
profile suited to living in diverse niches. Globally, T. gondii exhibits great genetic diversity 
that substantially impacts strain pathogenicity. Strains can be relatively benign and easily 
cleared, disease-causing and requiring treatment, or even lethal. For T. gondii to complete 
its lifecycle, however, it is important that during acute infection it is virulent enough to 
remain in the host but not too virulent to kill the host. The balanced infection that T. gondii 
seeks is one that generates a stable chronic infection. At this stage, the parasite 
developmentally switches to a slow dividing form and produces a tissue cyst structure 
around itself. The tissue cyst is orally infectious and resistant to immune attack and 
antibiotics. Completion of the lifecycle occurs when T. gondii tissue cysts are consumed 
by felines, often through a rodent meal, where conditions are suitable for sexual 
reproduction of the parasite. Oocysts, infectious to intermediate hosts, are then shed by 
felines through the feces, thereby continuing the lifecycle. Therefore, the balance between 
the parasite and the host is maintained by a constant battle between parasite virulence 
factors and the host immune system. Furthermore, a balanced infection in one host may be 
different for another host. This is evidence by the observation that T. gondii strains differ 
dramatically in virulence in laboratory mice (Howe and Sibley, 1995) and correlate with 
the severity of human toxoplasmosis (Khan et al., 2006; McLeod et al., 2012; Grigg et al., 
2001; Gilbert et al., 2008). This led to the hypothesis that different parasite strains have 
adapted to certain intermediate host niches (Boothroyd, 2009), defined by host genetics 
(Lilue et al., 2013).  This hypothesis has been expanded to postulate that in endemic 
regions, such as South America, T. gondii has adapted to immune hosts (Jensen et al., 
2015), and as such, certain strains of T. gondii may have virulence factors tailored to 
modulate adaptive immunity to establish a secondary chronic infection. However, this 
hypothesis was derived from observations made in C57BL/6 mice, which were highly 
susceptible to secondary infection with most virulent parasite strains tested (Jensen et al., 
2015). 
 
Here, we hypothesize that mouse genetics will influence the ability of mice to withstand 
virulent T. gondii secondary infection, and control the ability of T. gondii to form tissue 
cysts in challenged survivors. Furthermore, we hypothesize that mouse genetics will drive 
qualitatively different immunological memory responses and this will determine disease 
outcome. By studying these differences, and determining the genes and loci that promote 
mouse survival to secondary infection, we aim to uncover new requirements for immunity 
to T. gondii and define the adaptive niche that may have selected for virulent T. gondii 
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strains. In this chapter, a forward genetic screen and FACS analysis was used to understand 
how genetics impact immunity to T. gondii. The results herein, suggest a role for B-1 cell 
responses that are controlled genetically and their response correlates with host resistance 
to T. gondii.  
 
4.2 Results 
 
4.2.1 Mouse genetics influence the immunological memory 
response to virulent challenge with atypical Toxoplasma gondii 
strains 
 
We utilized C57BL/6 mice and A/J mice to assess whether their genetic differences 
correlated with host resistance to secondary infection with T. gondii. T. gondii infection 
has been extensively studied in the C57BL/6 background. Previous data from Jensen et al. 
show that when C57BL/6 mice are immunized with the avirulent type III CEP hxgprt-  
strain, mice survive secondary challenge with type I (RH), type II, and type III infection, 
but are very susceptible to “atypical” South American strains (2015). In contrast, we found 
that A/J mice were resistant to challenge with virulent atypical T. gondii strains (Fig. 7A). 
These results suggest that at least one or more genetic loci control resistance to secondary 
infection with T. gondii strains.  
 
4.2.2 The MHC locus offers protection against some strains of 
Toxoplasma gondii, but not all 
 
Disease outcome of toxoplasmosis in human populations is associated with host genotypes, 
including the MHC locus (McLeod et al., 1989). Polymorphisms in the MHC locus also 
confer susceptibility to chronic infection in mice (McLeod et al., 1989). To evaluate the 
impact of the MHC locus on the differences in mouse susceptibility to secondary infection, 
we performed a similar experiment with C57BL/10 (B10) and C57BL/10.A (B10.A) mice, 
both of which are of the C57BL/6 background (Fig.  7A).  B10 mice are closely related to 
C57BL/6 mice and differ by 310 non-synonymous SNPs and 159 exonic structural variants 
(Doran et al., 2016). The MHC congenic B10.A strain differs from B10 mice only at the 
MHC locus. B10.A mice encode the A/J MHC locus (H-2a) in place of the C57BL/6 MHC 
locus (H-2b). The H-2a locus encodes the MHC class I Ld which promotes resistance to 
cyst formation in type II chronically infected mice (Brown et al., 1995), likely due to the 
presentation of the polymorphic and protective type II GRA6 epitope (Blanchard et al., 
2008). Although the type III strain used to induce chronic infection in our model does not 
encode the GRA6 polymorphism required for epitope presentation by Ld (Lopez et al., 
2015), mice with the H-2a haplotype on average had less cysts and weighed more during 
type III chronic infection compared to mice with the H-2b locus (p < 0.04; Fig. 6).  
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As predicted, B10 mice challenged with atypical T. gondii strains succumbed to infection. 
However, B10.A mice were highly susceptible ( > 70% mortality) to challenge with certain 
atypical strains (VAND, GUY-DOS, GPHT, FOU) but displayed varying degrees of 
resistance to challenge with other atypical strains (TgCATBr5, MAS, GUY-MAT), 
indicating that the MHC locus confers resistance to certain T. gondii strains but not all in 
this system. Importantly, these data also indicate that the A/J genetic background encodes 
non-MHC-linked genes that control resistance to secondary infection with atypical T. 
gondii strains (Fig. 7A).  
 
4.2.3 Genetic mapping reveals two potential loci that determine 
host resistance to type I GT1 secondary infection 
 
To identify non-MHC loci that promote resistance to secondary infection, we chose to 
analyze the type I GT1 T. gondii strain, as this strain generates a lethal secondary infection 
in B10 and B10.A, but not in A/J mice or first filial generation A/J x C57BL/6 (F1) mice 
(Fig. 7B). Furthermore, unlike the highly passaged lab type I RH strain, GT1 elicits a lethal 
infection in C57BL/6 mice vaccinated with a uracil auxotroph vaccine strain (Jensen et al., 
2015). Our results testing F1 mice with secondary GT1 challenge indicate that the genetic 
loci protecting the resistant A/J strain are possibly haplo-sufficient, and likely, dominantly 
inherited. Interestingly, while both the A/J and F1 mice are resistant to challenge, the A/J 
mice exhibited far less superinfection in the brains of survivors (Fig. 7C and Table 2). Our 
data implies that virulence may be required to superinfect genetically resistant hosts like 
A/J mice, and can be entirely balanced in slightly less resistant hosts like F1 (A/J x 
C57BL/6) mice, in which no other symptoms—weight loss, dehydration, or lethargy (not 
Figure 6. Brain cyst burden and weight during chronic infection in A/J, C57BL/6, C57BL/10, and 
C57BL/10.A mice. A/J, C57BL/6 (B6), C57BL/10 (B10), and C57BL/10.A (B10.A) mice were injected 
with the type III strain CEP hxgprt- and allowed to progress to chronic infection. Plotted (+/- SEM) is 
the average cyst number (x 1000) in the brain vs. the average fraction of initial weight, where 1 is the 
normalized weight on the day of type III injection; the regression value (R2) is indicated. Results are from 
3 to 5 mice for cyst numbers (day 42 of chronic infection), and 5-12 mice for weight measurements (day 
30 of chronic infection) per mouse strain. 
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shown)—were noticed while nearly 90% superinfection rates were observed (Fig. 7C and 
Table 2). Superinfection may be a significant mechanism impacting the parasite population 
structure of T. gondii, because this presents two distinct T. gondii strains in a single meal 
consumed by the definitive host (Jensen et al., 2015). Following consumption, sexual 
recombination in the feline intestinal tract can lead to the production of genetically distinct 
parasite progeny. Thus, in the process of identifying A/J loci that determine immunity to 
secondary infection, the adaptive niche for the selection of virulent T. gondii strains may 
further be defined. 
 
Using the GT1 strain, a similar experiment was performed on 26 recombinant inbred (RI 
AxB, BxA) A/J x C57BL/6 mice strains, and survival to primary and secondary infection 
was assessed (Table 3). The RI mice contain an assortment of homozygous A/J and 
C57BL/6 alleles, which allows for the genetic mapping of loci that contribute to various 
phenotypes. Genetic mapping of secondary infection mortality revealed two distinct 
Quantitative Trait Loci (QTL) peaks with logarithm of the odds (LOD) scores greater than 
3 on chromosomes 7 (LOD = 3.57, imputed marker between rs8261820 and rs8261944) 
and 10 (LOD = 3.29, imputed marker between rs13480776 and rs13480777) (Fig. 8, A and 
B). Permutation testing (n = 1000) revealed neither of these two genetic loci reached 
significance (p < 0.05, LOD = 5.5). Reanalysis of McLeod et al.’s data derived from the 
same set of RI mice, which identified the MHC H-2a locus on chromosome 17 as a host 
resistance factor against tissue cyst generation during chronic infection, also produced a 
non-significant QTL peak (rs13482999, LOD = 2.65; n = 1000 permutations, n.s.; not 
shown).  Nonetheless, non-significant QTL peaks controlling complex traits can still lead 
to the identification of causal variants within a QTL region, as occurred for the 
identification of the H-2Ld gene as the resistance factor against type II tissue cyst 
generation (Brown et al., 1996). We also assessed superinfection in RI mice, although we 
did not genetically map this data; 52% of survivors were superinfected (Table 4).  
 
Given the major effects were dominated by two genetic loci, candidate genes within the 
location of the QTL peak were explored. A highly polymorphic gene candidate within the 
QTL region on chromosome 7 and closest to the genetic marker with the highest LOD 
score is nfkbid, NF-κB inhibitor delta (also known as IκBNS) (Table 5). The NFκB 
signaling pathway functions in almost all cell types, and regulates genes important for both 
the innate and adaptive immune responses (Hayden et al., 2006). NFκB has many roles—
it functions to induce the expression of proinflammatory molecules and functions in the 
activation and development of B and T lymphocytes (Livolsi et al., 2001; Gerondakis and 
Siebenlist, 2010). IκBNS is a member of the atypical NF-κB inhibitors, called nuclear IκBs, 
reflecting their restricted cellular localization. Unlike classical inhibitors of NF-κB, 
atypical NF-κB inhibitors can modulate NF-κB to induce or repress transcription (Schuster 
et al., 2013). Previous work has shown that mice deficient in IĸBNS signaling are deficient 
in B-1 B cell development and lack the ability to respond to T-independent type II antigens, 
antigens that engage with the B cell receptor (BCR) directly and induce B cell responses 
in the absence of CD4 T cell help (Touma et al., 2011; Arnold et al., 2012; Pedersen et al., 
2014). In general, NF-κB null mice have low levels of circulating IgM antibodies, an 
immunoglobulin important in the primary immune response to a variety of infections 
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(Obukhanych and Nussenzweig, 2006; Notley et al., 2010). Pedersen et al. showed that 
mutations in IκBNS reduce levels of circulating IgM, B-1 cells, and marginal zone (MZ) 
B cells, (2016). IĸBNS is also important for activation-associated cytokines in T cells 
including IL-2 and IFNγ (Touma et al., 2007). Interestingly, in RNA expression data from 
whole spleens C57BL/6 mice express greater nfkbid than A/J mice (Immgen.org; Heng et 
al., 2008) (Fig. 8). Whether these expression differences are observed during T. gondii 
challenge is unknown and warrants further investigation. 
 
Table 2. Superinfection of chronically infected mice challenged with virulent Toxoplasma gondii 
strains. Chronically infected C57BL/10, C57BL/10.A, A/J, F1 (A/J x C57BL6) mice were challenged 
with the indicated T. gondii strain; then, 35-45 days after secondary challenge, brains from surviving 
mice were homogenized in PBS and used to inoculate HFF monolayers. The resultant parasite cultures 
were then tested for the presence of the challenging strain (numerator = # of mice positive for challenge 
strain in brain, denominator = n mice tested that exhibited parasite growth in the HFF monolayer).  
1Parasite growth was observed in mycophenolic acid / xanthine medium, which selects for parasites 
encoding a functional HXGPRT (i.e. the challenging strains). 
Mouse Strain Chronic Infection Secondary Infection Heterologous Brain Infection?
C57BL/10 CEP hxgprt-  GUYMAT 1/1
1/1 = 100%
C57BL/10.A CEP hxgprt-  TgCATBr5 2/2
C57BL/10.A CEP hxgprt-  GUYMAT 2/2
C57BL/10.A CEP hxgprt-  MAS 1/2
C57BL/10.A CEP hxgprt-  FOU 0/1
5/7 = 71%
A/J CEP hxgprt-  GUYMAT 0/4
A/J CEP hxgprt-  TgCATBr5 0/5
A/J CEP hxgprt-  GUYDOS 4/5
A/J CEP hxgprt-  GT1 3/12
A/J CEP hxgprt-  VAND 4/6
A/J CEP hxgprt-  FOU 1/5
A/J CEP hxgprt-  GPHT 0/5
A/J CEP hxgprt-  MAS 0/5
11/40 = 27%
F1 CEP hxgprt-  GT1 8/9
8/9 = 88%
Total C57BL/10
Total C57BL/10.A
Total A/J
Total F1
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Figure 7. MHC is a protective factor against some Toxoplasma gondii strains, but not all. All mice 
were primed with 1 x 104 type III avirulent T. gondii CEP hxgprt-  parasites; then, 35 days later, mice 
were challenged with 5 x 104 of the indicated strain of T. gondii parasites. A) Survival of A/J [VAND (n 
= 7), GUYDOS (n = 5), GPHT (n = 5), FOU (n = 5), TgCATBr5 (n = 5), GUYMAT (n = 4), and MAS 
(n = 7)],  B10 [VAND (n = 4), GUYDOS (n = 4), GPHT (n = 4), FOU (n = 4), TgCATBr5 (n = 4), 
GUYMAT (n = 4), and MAS (n = 12)], and B10.A [VAND (n = 4), GUYDOS (n = 4), GPHT (n = 4), 
FOU (n = 4), TgCATBr5 (n = 4), GUYMAT (n = 5), and MAS (n = 10)]  mice following secondary 
infection with virulent atypical T. gondii strains. Results are from 1-2 experiments. Log-rank (Mantel-
Cox) testing was performed to calculate P values. For B10 mice, P values were calculated against the 
most lethal strain, VAND;  P = n.s. (GUY-DOS), 0.0404 (GPHT), 0.0082 (FOU), n.s. (TgCATBr5), 
0.0047 (GUY-MAT), and 0.0229 (MAS). For B10.A mice, P values were calculated against the most 
lethal strain, GUY-DOS; P = 0.0404 (VAND), n.s. (GPHT), 0.0082 (FOU, TgCATBr5, GUY-MAT), and 
0.0009 (MAS). B) Survival of B10 (n = 5), B10.A (n = 5), A/J (n = 12), and F1 (A/J x C57BL/6, n = 9) 
mice following secondary infection with the virulent T. gondii strain GT1 (top) and percent of 
superinfection in A/J (n = 12), F1 (A/J x C57BL/6, n = 9), with the virulent T. gondii type I strain, GT1. 
C) To evaluate superinfection, brains of mice were taken from secondary challenge survivors, emulsified, 
and grown in MPA-xanthine selection medium, which selects against the hxgprt- type III CEP strain used 
for chronic infection. The percent of mice for which the presence of the secondary parasite strain detected 
is plotted.  P values were calculated by Fisher’s exact test; ****P < 0.0001. 
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Table 3. Primary and secondary infection mortality of recombinant inbred (A/J x C57BL/6) lines 
following secondary challenge with GT1. 26 strains (n = 2) of RI mice were primed with 1 x 104 type 
III avirulent CEP hxgprt- T. gondii parasites; then, 35 days later, mice were challenged with 5 x 104 
virulent type I GT1 T. gondii parasites. Primary infection mortality indicates death following CEP hxgprt- 
infection and secondary infection mortality indicates death following GT1 infection.  
 
Recombinant Inbred Strain Primary Infection Mortality Secondary Infection Mortality
AXB1 0 100
AXB2 0 0
AXB4 100 N/A
AXB5 50 0
AXB6 100 N/A
AXB8 0 50
AXB10 100 N/A
AXB12 0 0
AXB13 100 N/A
AXB15 0 0
AXB19 0 100
AXB23 0 100
AXB24 0 100
BXA1 50 100
BXA2 0 100
BXA4 0 0
BXA7 0 100
BXA8 0 0
BXA11 0 100
BXA12 50 0
BXA13 0 0
BXA14 0 100
BXA16 0 100
BXA24 0 50
BXA25 0 0
BXA26 0 0
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Table 4. Superinfection of chronically infected recombinant inbred (A/J x C57BL/6) mice 
challenged with virulent Toxoplasma gondii strains. 35-45 days after secondary challenge, brains from 
the indicated RI mice were homogenized in PBS and used to inoculate HFF monolayers. The resultant 
parasite cultures were then tested for the presence of the challenging strain (numerator = # of mice 
positive for challenge strain in brain, denominator = n mice tested that exhibited parasite growth in the 
HFF monolayer).  
1Parasite growth was observed in mycophenolic acid / xanthine medium, which selects for parasites 
encoding a functional HXGPRT (i.e. the challenging strains). 
Mouse Strain Chronic Infection Secondary Infection  Heterologous Brain Infection?
AXB2 CEP hxgprt-  GT1 0/2
AXB5 CEP hxgprt-  GT1 1/1
AXB8 CEP hxgprt-  GT1 1/1
AXB12 CEP hxgprt-  GT1 2/2
AXB15 CEP hxgprt-  GT1 1/2
BXA4 CEP hxgprt-  GT1 0/1
BXA8 CEP hxgprt-  GT1 2/2
BXA12 CEP hxgprt-  GT1 1/1
BXA13 CEP hxgprt-  GT1 0/1
BXA25 CEP hxgprt-  GT1 1/2
BXA26 CEP hxgprt-  GT1 0/2
9/17 = 52%RI lines
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Figure 8. Two genetic loci on chromosomes 7 and 10 confer host resistance to virulent secondary 
Toxoplasma gondii infection. 26 recombinant inbred (A/J x C57BL/6) strains (n = 2) mice were primed 
with 1 x 104 type III avirulent T. gondii CEP hxgprt- parasites; then, 35 days later, mice were challenged 
with 5 x 104 virulent type I GT1 T. gondii parasites. A)  LOD scores for each marker were calculated and 
the running LOD scores of primary and secondary infection mortality is plotted. Quantitative trait loci 
(QTL) analysis was performed with the program R/QTL (Bowman). For all LOD scores > 2, 1,000 
permutations were performed to obtain the LOD threshold at a P value of < 0.05, which was considered 
statistically significant. Primary infection (black) indicates chronic infection with CEP hxgprt- and 
secondary infection (blue) indicates secondary infection with GT1. B) Effect plots of the genetic markers 
closest to the maximal LOD scores for chromosomes 7 and 10 is plotted. A/J (red) and C57BL/6 (blue); 
each point indicates mortality of one RI strain (n = 2) mice. 
 
Figure 9. Genetically mapped candidate genes exhibit expression differences between A/J and 
C57BL/6 mice. RNA was isolated from whole spleen in C57BL/6 mice and A/J mice and the normalized 
microarray chip intensities for the indicated genes are plotted (adapted from Immgen.org; Heng et al., 
2008). Gene expression data was averaged from 3 separate experimental data sets for each gene.  
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The second gene candidate, Tspan8 (tetraspanin 8), was found on chromosome 10; it is 
highly polymorphic between A/J and C57BL/6 mice, and is 6-fold more highly expressed 
in A/J mice than C57BL/6 mice in whole spleens (Hemler, 2005; Fig. 8 and Fig. 9). 
Tetraspanins are a group of cell surface proteins that function in motility, proliferation, 
activation, and growth. Tetraspanins, namely Tspan8, have been shown to be important 
mediators of cancer metastasis; melanoma cancers show higher expression of Tspan8 
(Berthier-Vergnes et al., 2011). Tetraspanin 8 interacts with integrins, which are known to 
be highly expressed on immune cells, and plays a role in lymphocyte function (Hemler, 
2005; Immgen.org; Heng et al., 2008). Perhaps tetraspanin 8 functions to assist immune 
cell migration during T. gondii infection. Further investigation should be done to determine 
Tspan8 expression in the context of T. gondii infection in A/J and C57BL/6 mice. Another 
potential, highly polymorphic, gene candidate near the peak on chromosome 10 is NeST, 
(Tmevpg1) a long non-coding RNA that controls microbial susceptibility and epigenetic 
activation of the IFNγ locus (Gomez et al., 2013). However, this gene is not directly within 
the confidence interval of the QTL.  
 
Of note, we found a small QTL peak (LOD = 1.97, rs3709414) on chromosome 17. 
Originally, we thought that an anti-sense transcript (Gm11110) to 4-1bbL (Tnfsf9) might 
be a likely candidate controlling expression of this costimulatory ligand found on antigen 
presenting cells that is polymorphic between A/J and C57BL/6 mice. 4-1bbL interacts with 
4-1bb, a costimulatory receptor located predominantly on CD8 T cells. 4-1bbL is a member 
of the tumor necrosis factor family and associates with TIRAP (Toll-interleukin 1 receptor 
adaptor protein) and signals through TRAF (TNF receptor associated factor) to activate 
NF-κB, a transcription factor important for microbial killing (Wang et al., 2009). However, 
we found 4-1bbL and 4-1bb expression to be very low or not expressed, without any 
obvious differences, on all immune cells that we looked at in both A/J and C57BL/6 mice 
(data not shown). It is unclear whether 4-1bb signaling differences exist between A/J and 
C57BL/6 mice.  
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4.2.4 Evaluating immunological differences between resistant 
A/J mice and susceptible C57BL/6 mice 
 
FACS analysis on isolated PECs was performed to assess a comprehensive view of the 
immune response differences between A/J and C57BL/6 mice in response to secondary 
infection with the virulent strain GT1. We investigated neutrophils, macrophages, dendritic 
cell subsets, CD4 and CD8 T cell effector populations and exhaustion marker expression, 
as well as conventional B-2 and B-1 B cells and their IgM expression. We found high 
numbers and frequencies of most of these immune cell populations—neutrophils, 
macrophages, dendritic cells, and CD4s—in C57BL/6 mice (Fig. 10); however, we found 
A/J mice had more than two times the number of CD8 T cells (Fig. 11A) and showed 
greater numbers of B-2 cells and B-1b cells (Fig. 17). 
 
4.2.5 C57BL/6 mice have reduced numbers of CD8 T cells and 
display a more exhausted T cell profile than A/J mice, but their 
T cells are functionally similar  
 
In the PECs, A/J mice have greater numbers (Fig. 11, A and C) and frequencies (Fig. 12, 
left)  of CD8 T cells than C57BL/6 mice by a factor of more than 2, while C57BL/6 mice 
have greater numbers (Fig. 11, B and D) and frequencies of CD4 T cells (Fig. 12, right); 
this trend also applies to each memory and effector memory population of CD4 and CD8 
T cells (Fig. 11, C and D). Generally, A/J mice display greater proportions of CD62L- TEM-
like and/or effector CD8 T cells while C57BL/6 mice display greater proportions of TCM-
like and/or naïve CD62L+ CD8 T cells following secondary infection (Fig. 11, E).  From 
our previous data (chapter 3), we knew that CD4 and CD8 T cells in C57BL/6 mice express 
exhaustion markers during secondary infection with virulent T. gondii strains. To evaluate 
Table 6. List of polymorphic genes within the confidence interval of mouse chromosome 10. All 
genes on mouse chromosome 10 that have at least one SNP between A/J and C57BL/6 and are between 
genetic markers with calculated LOD scores ≥ 1.7. The gene boundaries (in base pairs), MGI ID, symbol, 
gene feature type, and name for each gene is given. Additionally, the type of SNP is indicated as well as 
the total number of SNPs associated with each gene. All data is derived from MGI (Mouse Genome 
Informatics).  SNP, single nucleotide polymorphism; NS, non-synonymous; UTR, untranslated region; 
Syn, synonymous.  
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exhaustion profile differences in A/J and C57BL/6 mice, we evaluated PD-1, CTLA-4, 
TIM-3, and 4-1bb expression via FACS analysis (Fig. 13). While some exhaustion markers 
were more highly expressed in C57BL/6 CD8 T cells, namely TIM-3, CD4 T cells 
exhibited a more striking inhibitory receptor expression profile (Fig. 13). This is interesting 
considering the greater numbers of CD4 T cells present in C57BL/6 mice. Increases in 
exhaustion markers also tended to be higher in TEM-like than in TCM-like populations.  
 
We then tested C57BL/6 and A/J CD4 and CD8 T cells functionally by performing in vitro 
recall experiments to look at IFNγ production. Ex vivo PECs were infected with the type I 
RH T. gondii strain (recalled) followed by intracellular staining and FACS analysis. 
Despite exhaustion marker differences, there was no striking difference in IFNγ expression 
between A/J and C57BL/6 mice (Fig. 14). IFNγ is not the only readout for T cell 
dysfunction—cytotoxic molecules and other proinflammatory cytokines are often used to 
assess function—so other functional readouts should be performed. While these results did 
not exclude the possibility that T cell exhaustion plays an important role in secondary 
infection susceptibility, they potentially suggested that another immune mechanism was at 
play in host resistance.   
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Figure 10. Following challenge, A/J mice have greater frequencies of lymphocytes, while C57BL/6 
mice have greater frequencies of innate immune cells and antigen-presenting cells. Representative 
FACS plots from chronic and day 5 post challenge A/J and C57BL/6 mice. A/J (n = 10) and C57BL/6 (n 
= 10) mice were primed with 1 x 104 type III avirulent T. gondii CEP hxgprt- parasites; then, 35 days 
later, A/J (n = 5) and C57BL/6 (n = 5) mice were challenged with 5 x 104 virulent type I GT1 T. gondii 
parasites. On day 5 (D5) post challenge, PECs and spleen (data not shown) were harvested from chronic 
and D5 mice, washed with FACS buffer, stained on ice, and analyzed via FACS. Moving from left to 
right, gating strategy shown does not include exclusion of doublets.  
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Figure 11. Following challenge, A/J mice have greater numbers of CD8 T cells and display greater 
frequencies of CD8 T cell effectors following virulent challenge. Figure legend continued on next 
page.  
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Figure 11 (continued). A-E) A/J and C57BL/6 mice were primed with 1 x 104 type III avirulent T. gondii 
CEP hxgprt- parasites (chronic); then, 35 days later, A/J and C57BL/6 mice were challenged with 5 x 104 
virulent type I GT1 T. gondii parasites (D5). A-D) Graphs display data from one experiment showing 
quantification of CD8 and CD4 T cell effector populations from D5 A/J (n = 3) and D5 C57BL/6 (n = 3) 
PECs. 5mL of PBS containing 5 x 104 APC-conjugated CalBrite beads (BD Biosciences) was injected 
into peritoneal cavities of mice. PEC cells were isolated, washed in FACS buffer, stained, and analyzed 
by FACS. TCM-like (CD62L+), TEM-like (CD62L-KLRG1-), and activated TEM-like (KLRG1+). A) Total 
numbers of CD3+CD8+ PECs, B) total numbers of CD3+CD4+ PECs, C) total numbers of indicated CD8 
and D) CD4 T cell populations. P values were calculated by student’s t-test, unpaired; *P < 0.05. E) 
Representative FACS plots from chronic and D5 A/J and C57BL/6 mice. Pre-gating was performed to 
include lymphocytes and to exclude doublets and CD19+ cells.  
 
 
Figure 12. Following challenge, A/J mice have higher frequencies of CD8 T cells while C57BL/6 
mice have higher frequencies of CD4 T cells following virulent challenge. A/J and C57BL/6 mice 
were primed with 1 x 104 type III avirulent T. gondii CEP hxgprt- parasites (chronic); then, 35 days later, 
A/J and C57BL/6 mice were challenged with 5 x 104 virulent type I GT1 T. gondii parasites (D5). Graphs 
display data from one experiment showing percent of total leukocytes that are CD8 T cells (left) and CD4 
T cells (right) in A/J (n = 3 per group) and C57BL/6 (n = 3 per group) PECs during chronic and secondary 
infection with T. gondii. Pre-gating was performed to include CD3+ lymphocytes and to exclude doublets 
and CD19+ cells. P values were calculated by student’s t-test, unpaired, comparing chronic A/J to chronic 
C57BL/6 and D5 A/J to D5 C57BL/6; P values were not significant; P < 0.05 was considered significant. 
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Figure 13. C57BL/6 mice display exhausted marker profiles on CD4 and CD8 T cells following 
virulent challenge with Toxoplasma gondii. Exhaustion marker expression on CD4 and CD8 T cells 
from A/J and C57BL/6 PECs during chronic and day 5 following secondary infection with type I T. 
gondii GT1 parasites. Representative histogram plots are depicted from one experiment comparing A/J 
(n = 3 mice per group) and C57BL/6 (n = 3 mice per group), A) PD-1 expression, B) TIM-3 expression, 
C) 4-1bb expression, and D) CTLA-4 expression. Pre-gating was performed to include CD3+ 
lymphocytes and to exclude doublets and CD19+ cells. 
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4.2.6 Innate cells are more enhanced in C57BL/6 mice compared 
to A/J mice following infection with Toxoplasma gondii 
 
To broaden our view of the immune system beyond T cells, we investigated the response 
of macrophages and neutrophils during chronic infection and virulent challenge. Higher 
frequencies of macrophages and neutrophils were observed in C57BL/6 mice than in A/J 
mice during both chronic and secondary infections. (Fig. 15A). Both cell types play 
important roles in regulating the immune response to T. gondii, especially during primary 
infection; however, macrophage and neutrophil frequencies were specifically elevated 
following challenge (Fig. 15A). Macrophages are the preferred immune cell type infected 
by T. gondii, and as such, play an important role in the control and clearance of the parasite 
(Murray, 2011). Although macrophages are important in clearing T. gondii, they may play 
Figure 14. Despite exhaustion profile differences, T cells in A/J and C57BL/6 mice generate similar 
IFNγ responses. In vitro recall of IFNγ in CD4 and CD8 T cells from A/J and C57BL/6 mice during 
chronic and secondary infection with T. gondii. A/J and C57BL/6 mice were primed with 1 x 104 type III 
avirulent T. gondii CEP hxgprt- parasites (chronic); then, 35 days later, A/J and C57BL/6 mice were 
challenged with 5 x 104 virulent type I GT1 T. gondii parasites (D5). PECs were harvested from chronic 
and D5 mice, plated, and infected or “recalled” with type I RH T. gondii parasites at an MOI (multiplicity 
of infection) of 0.2. FACS analysis was then performed on surface stained and intracellularly stained 
(IFNγ-PE) recall PECs and spleens (data not shown). A) Percent of unstimulated IFNγ+ CD8+ PECs (left) 
and  percent of IFNγ+ CD4+ PECs (right) in chronic and D5 A/J and C57BL/6 mice. B) Percent of recalled 
IFNγ+ CD8+ PECs (left) and  percent of IFNγ+ CD4+ PECs (right) in chronic and D5 A/J and C57BL/6 
mice. P values were calculated by student’s t-test, unpaired; *P < 0.05.  
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a counterproductive role in C57BL/6 mice, where macrophages are more largely polarized 
towards alternative activation (Hassan et al., 2015). While neutrophils are known to 
produce IFNγ in response to T. gondii infection (Sturge et al., 2013), they have also been 
shown to increase parasite spread by acting as motile vessels that cross intestinal epithelium 
in C57BL/6 mice, although T. gondii was administered orally in this case (Coombes et al., 
2013). The spread of T. gondii throughout the host is facilitated by its exploitation of 
multiple different migratory immune cells (Courret et al., 2006; Lambert et al., 2006). 
 
We also observed greater frequencies of CD11b+CD11c+ and CD11c+CD8+ dendritic cells 
in C57BL/6 mice during both chronic and secondary infection, and greater frequencies of 
CD11c+CD8- dendritic cells in A/J mice (Fig. 15B). Like neutrophils, DCs have been 
shown to distribute T. gondii to different tissues, including immune-privileged organs like 
the brain, eye, and placenta (Montoya and Liesenfeld, 2004; Sanecka and Frickel, 2012). 
CD11c-expressing and CD11b-expressing immune cells, likely monocytes, have also been 
shown to transport T. gondii into the brain (Courret et al., 2006; Sanecka and Frickel, 2012). 
DCs are important in protecting against T. gondii through their innate functions in 
Figure 15. The innate response of C57BL/6 mice is more robust compared to A/J mice during 
Toxoplasma gondii infection.  A/J and C57BL/6 mice were primed with 1 x 104 type III avirulent 
Toxoplasma gondii CEP hxgprt- parasites (chronic); then, 35 days later, A/J and C57BL/6 mice were 
challenged with 5 x 104 virulent type I GT1 T. gondii parasites (D5). PECs and spleen (data not shown) 
were stained and FACS analyzed; n = 5 for all groups, except A/J chronic, where n = 4. A) Percent of 
leukocytes that are CD11b+ (CD11c- CD19-) macrophages (left) and Ly6G+ (CD19-) neutrophils (right). 
B) Percent of  three different CD11c+ (CD19-CD3-Ly6G-) CD11b+ (left), CD8+ (middle), or CD8- (right) 
dendritic cell (DC) subsets in the PECs of A/J and C57BL/6 mice during chronic and secondary infection 
with T. gondii. P values were calculated by student’s t-test, unpaired; *P < 0.05, **P < 0.01, ***P < 0.001, 
and ****P < 0.0001. 
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recognizing TLRs and producing IL-12 and also through their adaptive functions in antigen 
presentation to T cells. IL-12 production drives Th1 development and induces IFNγ 
responses, which elicits immune cell effector functions (Melo et al., 2011). Absence of 
CD8+ DCs, achieved with Batf3-/- mice, decreased production of IL-12 and IFNγ 
(Mashayekhi et al., 2011). In addition, CD8+ DCs are important for cross presentation of 
antigens derived from intracellular pathogens (Theisen and Murphy, 2017).  
 
4.2.7 B cell populations are deficient in C57BL/6 mice compared 
to A/J mice following virulent Toxoplasma gondii challenge 
 
We also analyzed the response of the B-cell compartment to secondary infection (Fig. 10). 
B-2 cells, or conventional B cells, are generated in the bone marrow and comprise the 
humoral arm of the adaptive immune system; they make antibodies, present antigens, 
produce cytokines, form memory cells, and predominate in the spleen (Pieper et al., 2013). 
B-1 cells, or innate-like lymphocytes, self-renew and are generated early in development 
within the fetal liver (Baumgarth, 2011). B-1 cells produce natural antibodies (i.e. IgM), 
predominate in the body cavities, and have been considered to lack the ability to form 
memory, although this has been disputed (Yang, Y. et al., 2012). During chronic infection 
C57BL/6 mice and A/J mice show similar frequencies of B-2 and B-1 cells, but after 
challenge the frequency of both B cell lineages appears to collapse in C57BL/6 mice while 
A/J mice retain their B cell frequencies (Fig. 16, left).  
 
To assess both cell numbers and frequency, and to identify B cell populations more 
thoroughly, we performed a secondary challenge experiment with A/J and C57BL/6 mice 
followed by FACS analysis to evaluate B-2 cells, B-1a cells, B-1b cells, and their IgM 
expression (Fig. 17, A and B). B-1 cells are divided into two lineages, B-1a cells and B-1b 
Figure 16. Frequencies of B-1 and B-2 cell populations are diminished in C57BL/6 mice following 
virulent challenge with Toxplasma gondii. Frequency of leukocytes of CD19+CD11b- B-2 (left) and 
CD19+CD11b+ B-1 (right) cells in the PECs of A/J and C57BL/6 mice during chronic and secondary 
infection with T. gondii. A/J and C57BL/6 mice were primed with 1 x 104 type III avirulent T. gondii 
CEP hxgprt- parasites (chronic); then, 35 days later, A/J and C57BL/6 mice were challenged with 5 x 104 
virulent type I GT1 T. gondii parasites (D5). PECs and spleen (data not shown) were stained and FACS 
analyzed; n = 5 for all groups, except A/J chronic, where n = 4. P values were calculated by student’s t-
test, unpaired; P < 0.05 was considered significant. 
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cells, both of which are derived from the fetal liver during early development (Hayakawa 
et al., 1985; Baumgarth, 2011). Both B-1a and B-1b cells reside predominantly in the 
pleural and peritoneal cavities, whereas B-2 cells predominantly reside in the spleen and 
lymph nodes. B-1a cells have polyreactive and self-reactive BCRs; they undergo positive 
selection on self antigens and are implicated in autoimmunity (Hayakawa et al., 1983). B-
1b cells have polyreactive BCRs but their developmental pathway is unclear (Baumgarth, 
2011). B-1 cells produce most of the circulating IgM, an immunoglobulin important in the 
activation of complement, neutralization of antigens, agglutination, precipitation, and 
enhancement of phagocytic clearance of dead and dying cells (Grönwall et al., 2012). They 
also produce natural IgA and IgG in a T-independent manner, in response to self-antigens 
(Berland et al., 2002). On day 5 following secondary challenge, C57BL/6 mice had similar 
numbers of B-1a cells in the PECs (Fig. 17B). For each B cell subset, IgM+ cell differences 
were observed between A/J and C57BL/6 mice, with C57BL/6 mice expressing more IgM 
(Fig. 17B). However, the most striking difference between A/J and C57BL/6 mice was an 
increased population of B-1b IgMlow cells in A/J mice (Fig. 17B). Because we only 
performed surface staining for IgM, it is unclear whether internal IgM is present. 
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Figure 17. A/J mice have enhanced B-1b cell production following virulent secondary challenge 
with Toxoplasma gondii. A) Gating strategy and frequencies of B-2 (B220hi CD19+ CD5- CD11b-), B-
1a (B220int-hi, CD19hi, CD5+ CD11b+), and B-1b (B220int-hi, CD19hi, CD5- CD11b+) populations in the 
PECs. B) Quantitification of B-2, B-1a, and B-1b cells in the PECs and their relative IgM expression 
(Mean Flourescence Intensity, MFI). Histograms are from representative samples (left); A/J (red) and 
C57BL/6 (blue). Quantification of IgMhigh and IgMlow B-1b cells in the PECs (right).  For A and B, PECs 
of A/J and C57BL/6 mice during secondary infection with T. gondii (GT1) were analyzed; n = 3 A/J and 
n = 3 C57BL/6. Student’s t-test, unpaired, was used to calculate P values. *P < 0.05 and **P < 0.01 were 
considered significant. 
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4.3 Discussion 
 
4.3.1 Immunological niche adaptation of Toxoplasma gondii 
 
As one of the most successful microorganisms on Earth, T. gondii infects myriad hosts, To 
do this, the parasite must be adaptable to changing immune environments. Some T. gondii 
strains, as shown in the secondary challenge experiments in Chapter 4, are better suited to 
coexist with certain hosts over others (Fig. 7). In order for T. gondii to promote niche 
adaptability it must be genetically diverse. T. gondii genetic divsersity can be achieved 
when sexual reproduction occurs in the definitive host, a feline. This can occur when the 
feline consumes a superinfected meal—prey infected with two or more T. gondii parasite 
strains. Interestingly, although F1 (A/J x C57BL/6) and A/J mice are both resistant to 
secondary infection with GT1, F1 mice are more likely (89% compared to 27%) to be 
superinfected. It seems that in nature, hosts that are analogous to F1 mice might be better 
suited to promote T. gondii strain diversity through superinfection, We hypothesize that 
strains which are better able to evade B-1b cell responses may be better suited superinfect, 
which in turn would promote expansion of strains with virulence factors to evade this cell 
type. One such candidate are the GPI-linked surface associated glycoproteins (SAG, or 
SRS), which represent the most polymorphic genes in T. gondii’s genome. There are over 
100 SRS genes and transgenic expression of SRS29C in the RH strain was shown to render 
it less virulent in naïve mice (Wasmuth et al., 2012). In light of our results, we hypothesize 
this surface antigen may be preferentially targeted by early B-1 cell antibody responses. 
Future experiments are aimed to test this hypothesis.  
 
4.3.2 T cells and B cells are protective against virulent challenge 
with Toxoplasma gondii 
 
While the well-established protective role of CD8 T cells is not being refuted by these A/J-
C57BL/6 differences during virulent challenge, as evidenced by elevated CD8 T cell 
numbers in A/J mice (Fig. 10A), the requirements for immunity are certainly broader than 
was originally hypothesized. However, the ability of T cells to produce IFNγ does not 
appear to account for mouse differences in generating immunological memory responses 
to T. gondii. This was demonstrated both by the ability of CD4 and CD8 T cells to produce 
similar amounts of IFNγ in response to parasite stimulation (Fig. 11B). Unexpectedly, B 
cell populations were significantly different between A/J and C57BL/6 mice following 
virulent secondary challenge (Fig. 17).  While B cells overall were more abundant in A/J 
mice, a specific population of B-1b IgMlow cells was increased in A/J mice by 
approximately 4 times that of C57BL/6 mice (Fig. 17B). We originally hypothesized that 
the resistant mouse would express more IgM, but similar expression, although slightly 
greater in C57BL/6, was observed. It may not be that the B-1b IgMlow cells are less 
functional; rather, they could be expressing a different immunoglobulin isotype such as 
IgG or IgA. In a study examining the roles of B-1a and B-1b cells during infection with 
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Streptococcus pneumoniae, Haas et al. demonstrated that B-1b cells generate induced IgM 
and IgG3 responses while B-1a cells produce low levels of natural IgM antibody—these 
two B cell subsets work together to facilitate innate and adaptive immune responses (2005). 
The elevated B-1b IgMlow population we observed could represent an induced, IgG3-
producing cell, as seen by Haas et al. To test this, we are currently staining B-1b cells from 
infected mice for surface and intracellular IgG3 expression. We are also working on 
invasion assays to assess whether the addition of different immunoglobulins, like IgG3 or 
IgM, inhibits T. gondii invasion into host cells or promotes opsonization.  
 
NF-κB is an important inducer of T and B cell development and activation. NF-κBid, or 
IκBNS, can induce or repress lymphocyte activation. Interestingly, Pedersen et al. showed 
that B-1a cells are absent and B-1b cells are greatly reduced in mice deficient in IκBNS 
(2014), an additional indicator that NF-κB is a likely gene candidate under the QTL peak 
on chromosome 7. We will be evaluating nfkbid expression in different A/J and C57BL/6 
immune cell populations, in particular B-1 cells, where we expect expression to be higher 
in A/J mice. 
 
Tspan8 is important for signal transduction, lymphocyte activation, and cell migration. 
This protein is found in many cell types, but is especially highly expressed on DCs 
(Immgen.org, Heng et al., 2008). Perhaps the expression of Tspan8, which is 6 times more 
highly expressed in A/J mice, facilitates migration of immune cells to the site of infection 
or allows antigen-presenting cells to migrate to and interact with lymphocytes. We will 
also be evaluating expression differences of this protein between A/J and C57BL/6 mice 
and potentially administering blocking antibodies to antagonize tetraspanin 8 signaling. 
 
 
4.3.3 Resistance versus tolerance to virulent challenge with 
Toxoplasma gondii 
 
An unusual phenomemon in A/J mice following virulent secondary challenge is the very 
quick initial clearance of the parasite followed by a short resurgence of the parasite (Fig. 
18). From this, one could draw the conclusion that the ability of A/J mice to survive is not 
merely due to a resistance mechanism, but also due to a tolerance mechanism. While the 
spike in frequency of  innate responders is indicative of failure to control parasite burden 
in C57BL/6 mice, these data might also suggest that macrophages, neutrophils, and some 
dendritic cell subsets might serve a detrimental role following virulent secondary infection 
with T. gondii.  In addition to greater frequencies of innate immune cells, C57BL/6 mice 
also produced greater amounts of CD4 T cells. Intestinal inflammation is a well-known 
trait in C57BL/6 mice following T. gondii infection, that is driven by Th1 responses that 
induce lesions and allow for gram negative bacteria to enter the lamina propria (Liesenfield 
et al., 1996; Raetz et al., 2013; Egan et al., 2012). The IFNγ-producing Th1 cells are the 
likely population comprising the CD3+CD4+ cells observed in C57BL/6 mice following 
challenge.  It is unlikely these cells are Tregs because they largely produce IFNγ and their 
CTLA-4 expression is not typical of that seen on a Treg (CTLA4hi). Regardless, the 
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distribution of various CD4 T cell subsets should be investigated in our model. Increases 
in CD4 T cells in C57BL/6 mice could be the result of inflammatory Th1 expansion or 
enhanced Treg expansion due to increased parasite burden. 
 
Furthermore, FAS ligand expression on B-1a cells has been shown to induce apoptosis of 
CD4 T cells during Schistosoma infection (Lundy and Boros, 2002). While CD8 T cells, 
B-1b cells, and B-2 cells likely play a protective role in A/J mice, C57BL/6 mice might be 
particularly susceptible to challenge not only because of an inadequate adaptive response, 
but also due to an overcompensatory, tissue-damaging innate response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Resistance and tolerance might be required for survival with virulent Toxoplasma gondii 
strains.  T. gondii parasite burden in A/J, B10.A, B10, and C57BL/6 mice following secondary infection 
with the virulent atypical strain MAS. Luciferase imaging shows representative mice that were primed 
with 1 x 104 type III avirulent T. gondii CEP hxgprt- parasites (chronic); then, 35 days later, A/J and 
C57BL/6 mice were challenged with 5 x 104 parasites of the virulent atypical MAS-luc (luciferase) T. 
gondii strain. B10 and C57BL/6 mice died by day 16, while A/J and B10.A survived. Images were taken 
under isofluorane anesthesia. 
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CHAPTER 5 
 
5.1 Introduction 
 
5.1.1 Development of T-GREAT, a transgenic IFNγ reporter 
mouse 
 
We developed a mouse model to track IFNγ production by CD8 T cells during T. gondii 
infection because of its known critical role in mounting a parasite-clearing immune 
response. To do this, we crossed T57 mice (Kirak et al., 2010) with GREAT (interferon-
gamma reporter with endogenous polyA transcript) mice (Reinhardt et al., 2009), which 
generated a new mouse line named T-GREAT. T57 transnuclear mice were generated by 
somatic cell nuclear transfer of Kb TDG05796–103 tetramer-positive CD8 T cells on the 
C57BL/6 background, and thus 90% of peripheral CD3+ T cells are CD8+ and 80 to 90% 
of these have endogenously rearranged TCRα (Vα6-4) and β (Vβ13-1) loci with encoded 
CDR3 regions bearing specificity for the T. gondii antigen Kb-TGD05796–103 (Kirak et al., 
2010). GREAT mice have an IRES-eYFP reporter cassette inserted between the 
translational stop codon and 3’ UTR/polyA tail of the interferon gamma gene. T-GREAT 
mice are homozygous for each of these three loci.  
 
5.1.2 Use of TGREATs 
 
The ability to track CD8 T cell activation and function through IFNγ responses could allow 
one to understand how hosts manage immune responses to different strains of T. gondii. 
Because IFNγ is a requisite for T. gondii clearance but is insufficient for the clearance of 
some T. gondii strains,  the T-GREATs were intended for the exploration of immune 
responses concurrent with the IFNγ response—through transcriptional analysis of T-
GREAT CD8 T cells in different infection contexts. Additionally, T-GREAT mice were 
intended for in vitro interrogation of killing of various T. gondii strains in the presence of 
T cell agonists and antagonists or following genetic modification with CRISPR-Cas9. The 
T-GREATs were also developed to evaluate regulators of the CD8 T cell IFNγ response 
during secondary infection by performing a forward genetic screen using a lenti-V2 
CRISPR-Cas9 library. However, the use T-GREATs in these contexts proved to be 
challenging as outlined below. 
 
 
 
 
 
 
 
63 
 
5.2 Results 
 
5.2.1 T-GREATs produce trackable CD8 T cell IFNγ responses 
to Toxoplasma gondii, but fail to persist in recipient hosts 
longterm 
 
We confirmed the presence of the desired rearranged T57 TCRα and TCRβ chains, and 
GREAT reporter by PCR (data not shown), and performed FACS analysis to confirm the 
functionality of the IFNγ:YFP bicistronic reporter (Fig. 19). For naïve T-GREAT cells to 
flux IFNγ, an antigen-presenting cell (i.e. bone marrow derived macrophages, BMDMs) 
had to be present, likely for costimulation, as there was no IFNγ:YFP signal detected in 
response to plate bound anti-CD3ε and anti-CD28 stimulation (not shown). Although IFNγ 
fluxed in vitro in the presence of parasite-infected BMDMs (data not shown), IFNγ 
expression was much more substantial with CD3 stimulation and BMDMs.   
 
To evaluate T-GREAT CD8 T cell expansion and IFNγ production in vivo, we performed 
adoptive transfer experiments by transferring (i.v.) 5 x 106 45.2+ T-GREAT CD8 T cells 
into 45.1+ (data not shown) or 45.1+/45.2+ mice, followed by injection with type II ME49 
or type III CEP hxgprt-  (Fig. 20). Peritoneal exudate cells (PECs), spleen (SPL), peripheral 
lymph nodes (PLNs, axillary, brachial, and inguinal), and mesenteric lymph nodes (MLNs) 
were isolated on day 9 following injection (Fig. 20, A-D), and PECs and SPL were isolated 
on day 35 post injection (Fig. 20E). Transferred CD8 T cells expanded significantly in the 
Figure 19. T-GREAT mice successfully produce IFNγ:YFP in response to stimulation. Splenocytes 
and lymph nodes were isolated, filtered, washed, negatively selected for CD8 T cells, and plated on bone-
marrow derived macrophages. Soluble CD3 was added when the CD8 T cells were added. 24 hours later, 
cells were stained and analyzed by FACS. Representative FACS plots, previously gated on live (PI-) 
CD19- cells, showing gating strategy of in vitro stimulated (top) and unstimulated (bottom) CD8+ T-
GREAT (T57 x GREAT IFNγ:YFP reporter) cells and histogram plots of IFNγ:YFP expression of CD3-
stimulated (red) and –unstimulated (blue) T-GREAT cells.  
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PECs (Fig. 20A), SPL (Fig. 20B), and MLNs (Fig. 20D), but expanded very little in the 
PLNs (Fig. 20C).  Furthermore, transferred CD8 T cells expanded more substantially in 
the presence of a more virulent type II T. gondii infection (Fig. 20, right) compared to a 
less virulent type III T. gondii infection (Fig. 20, left). Additionally, production of IFNγ by 
transferred CD8 T cells was considerably higher during type II infection. However, by day 
35, the CD8 T cell transfer population was barely detectable in recipient mice (Fig. 20E). 
Additionally, we were only able to evaluate the potential for day 35 expansion in recipients 
infected with type III T. gondii, as type II was lethal by day 35 in the same situation. To 
test whether clonal competition prevented longterm expansion, T-GREAT CD8 T cells 
were also transferred into CD8 knockout mice and compared to CD45.1 recipients. 
However, similar numbers of T-GREATs were detected in the PECs and spleens and 
neither recipient supported longterm expansion of T-GREATs. Furthermore, on day 9 of 
primary infection we had limited success sorting transfered CD8 T-GREAT cells, as the 
amount of cells sorted was minimal—approximately 1.35 x 105 cells for type II infection 
and 2.5 x 104 cells for type III per mouse (PEC)—a small fraction of the 5 x 106 CD8 T-
GREAT cells we originaly injected (data not shown).   
 
Because we were unable to get sufficient numbers of activated (IFNγ:YFP+) CD8 T-
GREATs, we attempted direct injection of T-GREAT mice with the replication-deficient 
uracil auxotroph type I strain RH Δompdc (vaccine strain) or the type II ME49 strain. We 
then sorted PECs and SPL from these mice. Although expansion was observed, cell 
numbers were still too low (~3 x 105 sorted cells) to be used for in vitro killing assays (data 
not shown). However, we were able to isolate RNA from IFNγ+ and IFNγ- CD8 T-GREAT 
cells for future transcriptional evaluation. 
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Figure 20. Adoptively transferred T-GREAT CD8 T cells successfully expand by day 9 in a 
recipient host following infection with type II and type III Toxoplasma gondii parasites, but the 
population collapses by day 35. Representative FACS plots showing transfer of CD8 T-GREATs in A) 
peritoneal exudate cells (PECs), B) spleen (SPL), C) peripheral lymphnodes (PLNs; axillary, brachial, 
and inguinal), and D) mesenteric lymph nodes (MLNs) of recipient mice on day 9 post infection with 
type II ME49 or type III CEP hxgprt- T. gondii strains. Spleens and lymph nodes from 6-8 week old 
female T-GREAT mice were isolated, filtered, washed, negatively selected for CD8 T cells, and washed 
in PBS. 5 x 106 45.2+ T-GREAT CD8 T cells were injected intravenously into the tail vein of 
heterozygous 45.1+/45.2+, 6-8 week old female mice. 12 hours later, 1 x 104 type II ME49 or type III CEP 
hxgprt- T. gondii parasites were injected. 9 days later, cells from indicated organs were isolated, stained, 
and analyzed by FACS on an Aria III. E) Similarly, 45.2+ T-GREAT CD8 T cells were adoptively 
transferred into  into 45.1 recipients, infected with the type III CEP hxgprt- strain and analyzed by FACS 
on day 35. 
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5.3 Discussion 
 
5.3.1 Kb-TGD05796–103 is a subdominant T cell receptor antigen 
which limits the use of T-GREATs 
 
While T-GREATs are a useful tool for tracking IFNγ production at early timepoints during 
primary infection, its use for tracking IFNγ responses during secondary infection have 
proved difficult. The inability of CD8 T cells to expand efficiently is likely due to T cell 
receptor (TCR) affinity problems or inefficient antigen presentation (McMurtrey et al., 
2013). Weak TCR:antigen interactions result in more rapid dissociation rates, reduced 
activation signals, and thus reduced clonal expansion (Stone et al., 2009). The Tgd057 
antigen is subdominant; other immunodominant T. gondii antigens have been identified 
(Blanchard et al., 2008; Sanecka et al. 2016). However, these transgenic mice and epitopes 
are specific to the BALB/c mouse background (H-2d). To get optimal numbers of T-
GREAT cells to assay killing of T. gondii, one would need a mouse on the susceptible 
C57BL/6 background with transgenic CD8 T cells specific for an immunodominant 
antigen, otherwise T-GREATs are of limited use for functional assays ex vivo. Ongoing 
experiments are underway to generate large numbers of activated T-GREAT cells, or 
“blasts,” by adding peptide and allowing to expand for 7 days in vitro. As expected, these 
T-GREAT blasts flux more IFNγ:YFP in response to stimulation and such blasts are being 
assayed for their ability to kill T. gondii parasite.  
 
 
Conclusion 
 
Both the innate and adaptive immune responses are robust during T. gondii infection. While 
several immune cells play important roles in clearing this parasite, two key players emerge 
in fighting this infection—T cells and B cells, specifically CD8 T cells and B-1b cells. 
Although CD8 T cells can control many T. gondii strains by IFNγ-mediated responses, 
several virulent, IFNγ-resistant strains elude this pathway. However, some hosts, like A/J 
mice, are able to clear T. gondii presumably by mechanisms other than the IFNγ response. 
Recent evidence points to extracellular killing of T. gondii by the cytotoxic molecule 
granzyme B (Dotiwala et al., 2016). One potential mechanism could be the induction of 
egress of T. gondii by CD8 T cells, where T. gondii becomes exposed to granzyme B or is 
inhibited by antibodies produced by B-1b cells. Opsonization by antibodies may promote 
the targeted killing of T. gondii or may block invasion of the parasite into a new host cell. 
To develop effective treatment and prevention against toxoplasmosis, it is important that 
we evaluate both the adaptive and humoral immune response to this ubiquitous and 
dynamic parasite.  
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